SNMMI POLICY CATALOG
Revised: September 15, 2012
TABLE OF CONTENTS
1.
Administrative Policies
Page 4
2.
American Board of Science in Nuclear Medicine (ABSNM) Page 6
3.
ACNP/SNM Joint Government Relations Committee
Page 7
4.
Board of Directors
Page 9
5.
Clinical Trials
Page 15
6.
Coding & Reimbursement Committee
Page 16
7.
Committee on Annual Meeting
Page 17
8.
Committee on Awards
Page 18
9.
Committee on Bylaws
Page 22
10. Committee on Chapters
Page 25
11. Committee on Continuing Education
Page 27
12. Committee on Councils
Page 28
13. Committee on Education
Page 31
14. Committee on Ethics
Page 34
15. Committee on Finance
Page 36
16. Committee on Guidelines and Communication
Page 46
17. Committee on Health Care Policy & Practice
Page 48
18. Committee on Nominations
Page 54
19. Committee on Publications
Page 55
20. Committee on Pharmacopeia
Page 59
21. Committee on Radiopharmaceuticals
Page 60
2
22. Committee on Scientific Program
Page 61
23. Cost Effectiveness Research
Page 63
24. Elections
Page 64
25. Government /Public Relations
Page 66
26. Historical Reference
Page 70
27. House of Delegates
Page 72
28. International
Page 75
29. Liaison/Related Organizations
Page 77
30. Membership Committee
Page 85
31. Meetings
Page 88
32. Molecular Imaging Center of Excellence
Page 93
33. Phantom Quality Assurance Committee
Page 95
34. PET Center of Excellence
Page 96
35. Political Action Committee
Page 98
36. Practice Guidelines Committee
Page 99
37. Procedure Guidelines Committee
Page 104
38. Professional Polices
Page 107
39. RADAR
Page 104
40. RadioImmunotherapy (RIT)
Page 110
41. SNM/Education and Research Foundation
Page 111
42. Task Forces
Page 112
43. Young Professionals Committee
Page 116
44. SNMMI-TS
Page 117
3
ADMINISTRATIVE POLICIES
000923
MOTION:
It was moved, seconded and voted that it is in the
best interest of the Society of Nuclear Medicine that
the SNM 401(K) Plan be amended and restated to
merge the Society of Nuclear Medicine Purchase Plan
into the 401 (K) plan; and, Resolved, further that the
officers of the plan are hereby authorized and
directed to take any actions necessary to carry out
the intention of this resolution; and, Resolved,
further, that the SNM Executive Director and SNM
Treasurer shall continue to serve as Trustees of the
Plan.
030125
030126
050616
REPORT:
Integration of new HIPAA language.
MOTION:
To include new HIPAA language into the SNM
Employee Manual Next review date 2008.
REPORT:
National Agenda and Roadmap for Biomedical
Imaging Research (NARBIR) SNM has been invited to
become a cosponsor for an initiative to develop a
National Agenda and Roadmap for Biomedical
Research (NARBIR). Although the major sponsors of
the project are the Academy of Radiology Research,
the ACR, the ARRS, and the RSNA, this effort is
intended to be a broad, multidisciplinary
collaboration. The purpose of the initiative is to
identify significant opportunities through which
imaging science can contribute to future advances in
clinical medicine and biomedical research.
MOTION:
To have SNM participate in the NARBIR program
REPORT:
The Sarbanes-Oxley Act requires that all nonprofit
organizations adopt a whistleblower policy. The policy
is very specific and provides a safeguard for the
Society and any staff member who feels compelled to
report an illegal activity. It was explained that if an
offense is reported to the Executive Director or
President, it does not stop there; the proper authorities
will be contacted as well.
MOTION:
To adopt the Whistlerblower policy into company policy.
4
070929BOD
MOTION:
It was moved, seconded and voted to approve; Vince
Pistilli, CFO; and Mike Nelson, COO as additional
signatories for the BB&T bank account.
090206
MOTION:
It was moved, seconded and voted to add the
whistleblower policy to SNM Employee Manual.
2010/0417BOD MOTION
It was moved, seconded and voted that the SNM Board
of Directors approve the form of amended SNM 401(k)
Plan effective October 1, 2009, and that an authorized
representative of The Society of Nuclear Medicine is
hereby authorized and directed to execute and deliver
to the Administrator of the Plan one or more
counterparts of the Plan.
2011/0122BOD MOTION
It was moved and unanimously voted to approve
adoption of default provisions within the SNM 401(k)
Plan to ensure compliance with the HEART Act as
follows:
a. Continued benefit accruals pursuant to the HEART Act
are not provided
b.Differential wage payments are treated as
Compensation for all Plan benefit purposes
c. The plan permits distributions pursuant to the HEART
Act on account of “deemed” severance of employment
Required Minimum Distributions (RMDs) for 2009 were
suspended unless a Participant or Beneficiary elected to
receive such distributions.
5
AMERICAN BOARD OF SCIENCE IN NUCLEAR MEDICINE (ABSNM)
Charging the President Appointed Task Force (see action item # 6) to consider having
the American Board of Science in Nuclear Medicine (ABSNM) develop a radiation
protection exam for use by the Nuclear Regulatory Commission (NRC) and agreement
states. (Resolution, February 1, 1998, House of Delegates) Next review date 2003.
6
ACNP/SNM JOINT GOVERNMENT RELATIONS COMMITTEE
941008EC-19
REPORT:
ACNP ECONOMIC IMPACT STUDY PROJECT: A COST
EFFECTIVENESS ANALYSIS OF HEPATOBILIARY
SCINTIGRAPHY, AN ECONOMIC IMPACT STUDY
The Executive Committee noted that the First
Progress Report by the University of Pennsylvania
PORT [Patient Outcomes Research Team] Biliary
Tract Disease Study is due on November 1, 1994.
The Society contributed $59,000 toward this study.
941008EC-01
PROJECT INTEGRATION
MOTION:
950212BOT-01
951021BOD-15
To endorse the concept of integrating appropriate
functions with the American College of Nuclear
Physicians (ACNP).
PROJECT INTEGRATION
MOTION:
To endorse the concept of integrating appropriate
functions of the Society of Nuclear Medicine (SNM)
with the American College of Nuclear Physicians
(ACNP).
MOTION:
To approve the proposal for an SNM/ACNP Joint
Government Relations Committee.
PROJECT INTEGRATION
MOTION:
960114
The Board of Directors direct the Department:
Meeting Services to configure a conjoint meeting of
the ACNP and the SNM in 1999 for Project
Integration.
STATEMENT OF COORDINATION OF ACTIVITIES
7
MOTION:
To endorse the Statement of Coordination of Activities
between the SNM, and ACNP. Next Review date 2001
MOTION:
Be it resolved that the SNM join with the other
member organizations of the ICANM/NCL to
invite ACNP to become a member with roles to
be determined later. (Resolution, February 1,
1998, House of Delegates) Next review date 2003.
MOTION:
Be it Resolved: That the ACNP/SNM supports the
shipment of Highly Enriched Uranium to AECL from
the U.S. for the development of the Maple Reactor
and to serve as a backup supply for the production of
MO-99. (Resolution, February 1, 1998, House of
Delegates) Next review date 2003.
980201
MOTION:
To discuss the submitted motion to consolidate the
following nuclear medicine organizations: The
American College of Nuclear Physicians (ACNP), the
American Society of Nuclear Medicine (ACNM), the
Institute for Clinical PET (ICP), and the American
Society of Nuclear Cardiology (ASNC). (Resolution,
February 1, 1998, House of Delegates) Next review
date 2003.
060211BOD
MOTION:
The ACNP-SNM Joint Government Relations
Committee (GRC) recommends the SNM: a) continue
to pursue the restoration of government funding for
basic nuclear medicine research; b) designate a task
force to collect data from the national laboratories
and universities regarding the research and the
impact of the funding cuts.
060602BOD
MOTION:
The SNM-ACNP Joint Government Relations
Committee hereby resolves that the SNM BOD should
authorize the expenditure of at least $10,000 to the
AMA next fiscal year for the purpose of facilitating
SNM participation in the reevaluation of specialty
practice expenses.
98021
8
BOARD OF DIRECTORS
960602
000602
REPORT:
Members of the Committees of the Board of
Directors serve for a term of three (3) years,
with a maximum of two (2) full terms, with the terms
staggered, so that three (3) are appointed each year
and with understanding that the Chairman will come
from one of the nine (9) committee members.
Exceptions to the number of committee members are
noted in PROCEDURES.(Resolution, June 2, 1996,
House of Delegates) Next review date 2001.
MOTION:
It was moved, seconded and voted to approve the
Procedures document as amended(Resolution,June14,
2002, Board of Directors) Next review date 2007.
MOTION:
It was moved, seconded and voted to approve the
revised SNM Procedures document. (Resolution, June
15, 2002, Board of Directors) Next review date 2007.
MOTION:
It was moved, seconded and voted that the Board of
Directors authorize continued work on development of
a petition for exemption from NRC regulation of
diagnostic nuclear medicine and to form a task force
to accomplish this purpose.
It was moved, seconded and voted that the Board of
Directors approve additional funding from the general
fund, not to exceed $15,000, for outside counsel to
work with the task force on the petition.
It was moved, seconded and voted that the Board of
Directors approve funding for outside counsel, in an
amount not to exceed $15,000, to review new NRC Part
35 and associated regulations for possible legal action
and filing said action.
It was moved, seconded and voted that a task force be
formed to evaluate the methods used by the relevant
agencies to establish the levels of physician
reimbursement for Nuclear Medicine procedures to
develop data supporting alternative reimbursement
schemes and to recommend strategies to improve
9
nuclear medicine physician reimbursement.
It was moved, seconded and voted that the Board of
Directors reimburse the SNM Education and Research
Foundation $10,300 for the year 2000 contribution to
the American Academy of Radiology Research.
020614BOD
MOTION:
It was moved, seconded and defeated to add
Scientific Program Chair as an ex-officio member of
the Board of Directors.
050617BOD
MOTION:
It was moved, seconded and voted to approve the
Governance Reimbursement Policy as amended,
attached as (APPENDIX 1).
070216BOD
MOTION:
Resolve that the BOD create a working committee
involving the Councils (at least RadioPharm and C&I) to
investigate the feasibility and necessity of curricula for
training of scientist in nuclear medicine and molecular
imaging.
060601BOD
MOTION:
Be it resolved, That it is the expectation of the SNM
Board of Directors that SNM leadership is the primary
contact with industry in terms of introducing them to
the SNM and the MI Campaign activities.
The SNM Board of Directors is grateful to Dr. Conti
for his offer to continue to be involved with the MI
Campaign and hope that he will agree to continue to
ensure deals are closed.
The SNM Board of Directors recognizes that time off
from work will be required in some cases and has
authorized, for a two-year period, the for release time
be paid to his institution for time off up to $30,000 to
ensure appropriate funding from industry is obtained.
SNM staff and leadership will negotiate the contact
with Dr. Conti for his services.
071113BOD
MOTION:
It was moved, seconded and voted to accept the
Siemens Business Awards restricted fund and move
forward immediately with advertising and marketing
for the awards.
10
021608BOD
MOTION It was moved, seconded and voted that the grant
proposal supporting the creation of PET/CT education
in programmatically accredited programs be sent to
the MI Awards Committee for support, in proposed
amount of $22,500.
080612BOD
MOTION It was moved, seconded and voted to approve the
Board Expectations as outlined in (Appendix 63).
090611BOD
MOTION It was moved, seconded and voted to revise the core
values, as included in the SNM Strategic Plan, to
include: “dedication to education and research.”
It was moved, seconded and voted to revise the Big
Audacious Goal to the following:
1.“Advancing” to “integrating and advancing”.
2.“SNM will be the leader of increasing the utilization
of medical imaging technologies in clinical health
care.”
3.“SNM will be the leader in advancing molecular
imaging and therapy and integrating molecular
imaging into clinical practice.”
4.The board also agreed to add the following bullet
point to the vivid description under the B.A.G. –
“increase the appropriate utilization of molecular
imaging technologies in health”.
It was moved, seconded and voted that Goal B: SNM
will be the powerful advocate for molecular medicine,
including imaging and therapy; be revised to the
following: “SNM will be the powerful advocate for
molecular imaging. SNM will be the advocate for
molecular medicine, including imaging and therapy.”
090913BOD
MOTION
It was moved, seconded and voted to accept “SNM
will be the leader in advancing molecular imaging and
therapy and integrating molecular imaging into clinical
practice” as the new Big Audacious Goal for SNM.
It was moved, seconded and voted to hold an
expanded Spring Board Meeting to include Committee
and Commission chairs.
2010/0418BOD
MOTION
It was moved, seconded and voted to amend the
11
Mission to read ”To improve human health by
advancing molecular imaging and therapy”
It was moved, seconded and voted to change the
core values to the following; honest and ethical
behavior, integrity, commitment to optimal patient
care, respect for all, foster inquiry and reflection,
courage and leadership in the face of change,
professionalism, commitment to excellence.
2010/0603BOD
MOTION
It was moved, seconded and voted to approve the
strategic plan as presented, and prioritized by the
Board of Directors. (Appendix 27)
2010/0720BOD
MOTION
It was moved, seconded and voted to approve the
creation of the Outreach Committee.
2010/0913BOD
MOTION
It was moved, seconded and voted that the SNM
Board of Directors approve the Levels of Competency
Determined by Length of Training in Nuclear
Medicine Article for JNM Newsline (APPENDIX 62)
It was moved, seconded and voted that the SNM
Board of Directors approve the Conjoint Statement of
the SNM, ACNM and ABNM on Credentialing and
Delineation of Privileges for Therapeutic Procedures
Using Radiopharmaceuticals. (APPENDIX 28)
It was moved, seconded and voted that the SNM
Board of Directors approve the revised language for
the ACR-SNM Technical Standard For Diagnostic
Procedures Using Radiopharmaceuticals Guideline in
Title and Section III of the ACR-SNM guideline.
(APPENDIX 29)
2011/0121BOD
MOTION
It was moved, seconded and unanimously voted to
add a new goal “Goal G: “Molecular imaging
biomarkers and molecular imaging agents will be
used as a part of clinical management and clinical
trials” to the SNM Strategic Plan (APPENDIX 30).
2011/0122BOD
MOTION
It was moved, seconded and unanimously voted to
approve the ACR-SNM Task Force on Nuclear
Medicine Training Report (APPENDIX 31).
2011/0211BOD
MOTION
It was moved, seconded and unanimously voted to
12
approve the 2020 Nuclear Medicine and Molecular
Imaging Task Force proposal (APPENDIX 32).
2011/0602BOD
MOTION
It was moved, seconded and voted to approve the
revised committee structure and the committee
chairs for the 2011-2012 board year(APPENDIX 33).
It was moved, seconded and unanimously approved
to create 20/20 Nuclear Medicine and Molecular
Imaging Task Force to investigate the future of
nuclear medicine. The final proposal (including
timeline and budget) will be sent back to the board
for review and approval.
2011/0501BOD
MOTION
It was moved, seconded and unanimously voted to
approve removing the current tagline, if the
proposed name change is approved. (If there is no
name change, then the tagline will remain.)
It was moved, seconded and voted to approve the
following acronym “SNMI.”
2011/0918BOD
MOTION
It was moved, seconded and voted unanimously to
approve the output of the task force in the form of
the two scenarios. The best scenario is nuclear
medicine remains a primary specialty evolving into a
broader based discipline of molecular imaging, with
partnerships and collaboration as necessary. The
most likely scenario is that the field is advanced by
dual certified (ABNM/ABR or other) professionals,
who practice the broad based discipline of molecular
imaging.
2011/1026BOD
MOTION
It was moved, seconded and voted to approve the
SNM comment letter to the NRC. (APPENDIX 68)
2012/0608BOD
MOTION
It was moved, seconded and voted to approve the
SNM Position Statement on Dose Optimization for
Nuclear Medicine and Molecular Imaging Procedures
found under (APPENDIX 79).
2012/0608BOD
MOTION
It was moved, seconded and voted to approve the
SNM/ABNM Joint Position Statement on Optimizing
Training in Nuclear Medicine in the Era of Hybrid
Imaging.
13
2012/0809BOD
MOTION
It was moved, seconded and voted to move forward
with Task Force III in conjunction with the ACR.
14
Clinical Trials
050918BOD
080614BOD
MOTION:
It was moved, seconded and voted that the
Board approves the establishment of a limited
liability corporation (LLC) for the Nuclear
Medicine Clinical Trials Group.
MOTION:
It was moved, seconded and voted to approve
the request of the Committee on Pharmacopeia,
Radiopharmaceutical Sciences Council, to collect
adverse reactions from various institutions and
distribute them on the Nuclear Medicine Clinical
Trials Group’s website. This should be
conducted under the auspices of the Nuclear
Medicine Clinical Trials Group, LLC.
MOTION:
It was moved, seconded and voted to support
the Clinical Trials initiative.
15
CODING & REIMBURSEMENT COMMITTEE
050918BOD
MOTION:
It was moved, seconded and voted to
approve charging non-SNM members a $100
annual fee to access coding and reimbursement
information via the SNM website.
060602BOD
MOTION:
The Committee recommends to the BOD that the
SNM contribute $10,000 to participate in the
upcoming AMA multi-specialty survey to improve
the underlying practice cost data utilized to
allocate Medicare practice expense payments.
16
COMMITTEE ON ANNUAL MEETING
030602
MOTION:
To approve a $10,000 line item to pay honorariums
for two high profile guest speakers to present at the
plenary sessions during the 2004 Annual Meeting in
Philadelphia. (Resolution, June 20, 2003, Board of
Directors) Next review date 2008
050617BOD
MOTION:
It was moved, seconded and voted that for 2006:
1. All annual meeting pre-registrants be sent printed
copies of the Abstract Book prior to the annual
meeting
2. On-site registrants receive a printed copy of the
Abstract Book; and
3. The abstracts on CD should be sent to all Society
members with the May issue of JNM.
17
COMMITTEE ON AWARDS
960114HOD-ACC NOMINATION OF THE AEBERSOLD AWARD
MOTION:
950212BOT-23
To approve the nomination of Kenneth A. Krohn for
the 1996 Aebersold Award.
ANNOUNCEMENT OF THE 1995 SNM CANDIDATES FOR AWARDS
MOTION:
To approve the following recommendations for the
1995 SNM Awards as submitted by the SNM
Committee on Awards: The Paul Aebersold Award to
John A. Katzenellenbogen, Ph.D.; The Mallinckrodt
Fellowship Award to Fidelma Louise Flanagan, M.D.;
Dupont Pharma Fellowship for Research in
Cardiovascular Nuclear Medicine to William H. Devlin;
The Distinguished Service Award to Katherine A.
Lathrop.
960112BOD-SPC NUCLEAR MEDICINE LECTURESHIP
MOTION:
950610BOD-10
The Nuclear Medicine Lectureship shall be named in
honor of Dr. Henry N. Wagner, upon completion of
the 1996 Nuclear Medicine Lectureship.
AWARDS COMMITTEE
MOTION:
To accept the concept of expanding the Luncheon for
the Past Presidents to include the major award
winners, but to table the final recommendation to
hold a permanent type of awardees luncheon until
the 1996 Midwinter Meeting, due to the following: a)
the committee needs to review participants invitation
roster and) the committee does not want this process
to be executed in an ad hoc manner.
030405
MOTION:
It was moved, seconded and voted to approve the
ERF/SNM Alliance document. (Resolution, April 4-5,
2003, Board of Directors) Next review date 2008.
03062
MOTION:
It was moved, seconded and voted to approve
the establishment of the Cassen Lectureship
Award from the Education and Research
18
Foundation and that the Scientific Program
Chair, General Program Chair, and President
will consult widely to determine speakers and
awardees. (Resolution, June 20, 2003, Board of
Directors) next review date 2008.
050617BOD
MOTION: It was moved, seconded and voted to change the
term of the Awards Committee Chair from one year to
three years.
060910BOD
MOTION: It was moved, seconded and voted to approve the
Committee on Awards recommendation that the
BOD increase funding for the Pilot research grants to
$25,000 per grant. To fund this, the President will
request the additional funding from the Education
and Research Foundation.
070415BOD
MOTION: It was moved, seconded and voted that commercial
support be sought for continuation of the Visiting
Scientist/Physician Program Grants funded by GE
Healthcare in 2006, addng to the program a
component that would support a visit by a
physician/scientist from the developing country to
North America.
MOTION: It was moved, seconded and voted that SNM will
work with Nihon Medi-Physics Co., Ltd. (NMP), the
sponsor, to establish and direct the Wagner-Torizuka
Fellowship Program to bring young Japanese
physicians to the U.S. for a two-year fellowship in
nuclear cardiology, nuclear oncology or nuclear
neurology.
FALL 2004 BOARD OF DIRECTORS MEETING
Scholarship, Fellowship & Grant Programs
Frances Keech gave an overview of the program and ERF position. The following list of
scholarships, grants and fellowships summarize the programs more fully described in
the document “Funding Opportunities and Priorities for 2005” presented in the BOD
agenda. These program descriptions were first discussed by the SNM BOD in June and
have been revised to reflect the comments from that meeting. They represent the kind
of support needed to advance education and research in nuclear medicine. Upon SNM
19
BOD approval they will become the fundraising priorities for the Education and
Research Foundation.
Name
Amount
Scholarship in Molecular Imaging
Career Development Grant in CI
Clinical Fellowships in PET/CT
Technologist Scholarships in PET/CT
Program Development Grant in PET/CT
Research Fellowship in MI and Therapy
Seed Grant in Nuclear Medicine Research
Fellowship Stipends in NM Research
International Fellowships in Nuclear Medicine
$30,000
$100,000
$45,000
$10,000
$100,000
$120,000
$25,000
$45,000
$50,000
Minimum
Number
One
One
One
Five $2k each
One
One $60k/yr-2yrs
One
Three $5k/yr-3 yrs
Five $10k each
TOTAL $525,000
Dr. Royal pointed out that the list summarizing the priorities omitted the travel awards
at $10,000 (five awards for $2,000 each).
FALL2004
MOTION: To approve the SNM Funding Opportunities and
Priorities for 2005.
090206
MOTION: It was moved, seconded and voted that the following
policy be adopted for the creation of Named Lectures
held at the SNM Mid-Winter or Annual Meetings: All
councils must submit proposals for named lectureship
to the Scientific Program Committee (SPC) by July of
previous year in which they wish to hold the lecture.
The SPC will review these proposals and make a
recommendation to the SNM BOD for final approval.
(All current lectures held during the Mid-Winter or
Annual Meeting shall be grandfathered in.)
2010/0604BOD
MOTION
It was moved, seconded and voted that the SNM
Awards Committee, in concert with the Scientific
Program Committee, initiates a Hal Anger Prize based
on one of the major research awards already offered
by SNM. The Anger Award will be given every other
year, rotating with the current Cassen Prize. A Hal
Anger Lectureship should be part of the Annual
Meeting plenary session where the Hal Anger Prize is
20
awarded; the lecture would be of fitting quality of the
plenary session to maintain the quality of the plenary
program. In addition, the Awards Committee, SPC
and ERF will work together to establish the details of
the prize and lectureship to ensure no confusion with
the existing Academic Council Hal Anger award.
2011/0122BOD
MOTION
It was moved and unanimously approved that the
Anger Lecture be given every other year (alternating
with the Cassen Lecture) and that the recipient will
receive $5,000 as well as the opportunity to present a
plenary session lecture. Further, the recipient of the
Anger Lecture will be chosen by a collaboration of the
Scientific Program Committee, the ERF and the
Academic Council. The Anger Prize will be renamed
the “Anger Molecular Imaging Research Grant for
Junior Medical Faculty” and will replace the “SNM
Molecular Imaging Research Grant for Junior Medical
Faculty.” The awardee will be chosen by the Grants
and Awards Committee
2011/0211BOD
MOTION
It was moved, seconded and voted to approve the
spending of the Bob Lull Fund, to the ACNM, in the
amount of $4,300.
2012/0809BOD
MOTION
It was moved and voted to approve the SNMMI Grant
and Awards Committee recommendation for the
disbursement of the remaining $50,000. (APPENDIX
75)
2012/0608BOD
MOTION
It was moved and voted to approve the Pediatric
Investigator Awards - Majd-Gilday Young Investigator
Award and Conway-Treves Senior Investigator Award.
2012/0608BOD
MOTION
It was moved and voted to approve the revisions to
the Radiopharmaceutical Sciences Berson-Yalow
Award description.
21
COMMITTEE ON BYLAWS
The Committee on Bylaws received notice of and reviewed the proposed amendments
to the SNM Bylaws. As required by the Bylaws, notice of these proposals were published
to the membership at least 60 days prior to the next meeting of the House of
Delegates. The SNM Bylaws require a two-thirds vote of the House of Delegates to
approve any amendments to the bylaws.
970209
MOTION:
To approve the above-referenced Bylaw Amendments
as submitted. (Resolution, February 9, 1997, House of
Delegates. Next review date 2002
970209
MOTION:
000603
MOTION: It was moved, seconded and voted that the Bylaws
Committee be instructed to develop an amendment to
the SNM Bylaws which would remove the structural
layer of Commissions of the House of Delegates while
retaining the current functional committees structure.
(Resolution, June 3, 2000, House of Delegates. Next
review date 2005.
010623
To approve the SNM revised Mission Statement.
[if this action is approved by the House of Delegates,
protocol to amend the SNM Bylaws, Article II,
Section I, “Mission” will be subsequently initiated.]
(Resolution, February 9, 1997, House of Delegates)
Next review date 2002.
MOTION:
It was moved, seconded and voted that the Bylaws
Committee develops an amendment to permit the
disciplining of members. (Resolution, June 3, 2000,
House of Delegates) Next review date 2005
MOTION:
It was moved, seconded and voted that Article III,
Section 4 of the SNM Bylaws concerning the discipline
of members is changed as identified in Exhibit “B”.
(Resolution, June 23, 2001, House of Delegates) Next
review date 2006.
22
062301
MOTION:
To amend Article XII of the SNM Bylaws removing
reference to Commissions and replacing those with
committee as listed on Exhibit “C” with the addition
of the Committee on Health Care Policy and Practice.
(Resolution, June 23, 2001, House of Delegates) Next
review date 2006.
MOTION:
Bylaws language be developed designating the Board
Of Directors as the governing body of the Society,
and that language presented to the House for
adoption at its next regularly scheduled meeting.
Approved June 23, 2001 House of Delegates. Next
review date 2006.
020902
MOTION:
To approve an amendment to the Bylaws, clarifying
the institutional status of chapters within the SNM.
Approved February 9, 2002 Board of Directors. Next
review date 2007.
020902
MOTION:
To approve the amendment to the bylaws concerning
membership status and payment of dues. Approved
February 9, 2002, Board of Directors. Next review
date 2007
070531BOD
080215BOD
MOTION:
The motion was moved, seconded and approved to
recommend that the SNM Bylaws Committee remove
Annual Meeting, Commercial Committee names, and
changing the Committee on Health Care Policy and
Practice to Committee on Health Care Practice on the
Standing Committee list of the SNM Procedures
document.
MOTION:
The motion was moved, seconded and approved
that the Chairperson of the Committee on Awards
shall be the SNM Immediate Past President.
MOTION:
It was moved, seconded and approved that the
Immediate Past President shall not be eligible to be
nominated for a position for a period of 3 years.
MOTION:
It was moved, seconded and voted to approve the
proposed amendment to the proposed Procedure
change to read: The Immediate Past President shall
23
not be eligible to be nominated for an elected position
for a period of 3 years.
080612BOD
MOTION:
It was moved, seconded and voted to add the
Speaker of the HOD as a voting member of the SNM
Board of Directors.
MOTION:
It was moved, seconded and voted to approve the
ERF President as a non-voting member of the SNM
Board of Directors.
MOTION:
It was moved, seconded and voted to add the
Scientific Program Chair as a non-voting member to
the SNM Board of Directors.
MOTION:
It was moved, seconded and voted to approve the
Commission/Committee appointments as outlined in
(Appendix 22).
24
COMMITTEE ON CHAPTERS
960112BOD-NBA SNM BOARD LIAISON TO THE SNM COMMISSION ON SNM
REGIONAL CHAPTERS
MOTION:
950609BOD
Be it resolved that the SNM President-Elect will serve
as the official liaison to the SNM Commission on SNM
Regional Chapters and chair meetings of the
Commission. In the event that the SNM President
Elect cannot be present for an individual meeting of
the Commission, the SNM President will designate
another member of the Board of Directors to exercise
this responsibility. The meeting of the Commission on
Regional Chapters should be so schedule as not to
conflict with the official Mid-Winter and Annual
Meeting schedules of the SNM President-Elect.
REQUEST TO DISSOLVE THE QUEBEC CHAPTER OF THE
SOCIETY OF NUCLEAR MEDICINE
MOTION:
Whereas, it is the unanimous opinion of the Executive
Committee and of the polled membership of the
Quebec Chapter of the Society of Nuclear Medicine,
who are all very proud of belonging to the Society of
Nuclear Medicine and fully intend to remain members
of this Society, that the Chapter as such has no future
due to the fact that any function it could assume is
already very well covered by other local association,
And whereas, the continuing existence of the Quebec
Chapter of the Society of Nuclear Medicine would
merely generate continued wasteful exchanges of
correspondence and other material, to the detriment
of the Society of Nuclear Medicine,
BE IT RESOLVED, that the Charter for the Quebec
Chapter of the Society of Nuclear Medicine be
revoked by the House of Delegates, and that the
members of this Chapter retain the status of Members
At Large of the Society of Nuclear Medicine.
ACCEPTED. Chapter chartering process and charters
for both incorporated and unincorporated chapters.
(Resolution, February 9, 2002, BOD), next review
date 2007
25
2012/0429BOD MOTION
It was moved, seconded and unanimously voted to
allow SNM affiliated chapters to utilize “doing
business as (DBA).” Chapters will be able to utilize the
“doing business as (DBA)” function for the
foreseeable future.
2012/0608BOD
It was made, seconded and voted to approve Puerto
Rico as an honorary chapter awaiting the formal
paperwork from Puerto Rico and approval from the
Committee on Chapters and House of Delegates.
MOTION
26
COMMITTEE ON CONTINUING EDUCATION
Fall 2004 SNM Board of Directors Meeting
Revised SNM CME Mission Statement
In accordance with sound educational practice, SNM reviews its CME mission statement
periodically to ensure that the mission includes the purpose, content areas, target
audience, type of activities provided, and expected result of the program. To that end, the
Continuing Education Committee reviewed the existing mission statement and submitted
the proposed revised CME Mission Statement to the board for approval.
MOTION: A motion was made to approve the Revised SNM CME
Mission Statement. The motion was seconded and voted
to approve the revised SNM CME Mission Statement
attached as (Appendix 2)
060602BOD
MOTION: Be it resolved that SNM Approve the Separation Of
Education Activities and Commercial Promotion CME
Policy.(APPENDIX 3)
090612BOD
MOTION It was moved, seconded and voted that the revised
Continuing Medical Education Conflict of Interest Policy
be approved. (APPENDIX 34)
2012/0608BOD
MOTION It was moved, seconded and voted to amend the
guidelines for CE applications to increase the timeline
for Joint Sponsor CE applications from 60 to 90 days.
Any application received after the 90 day deadline will
incur a $300 dollar late fee. This change would be
effective immediately.
27
COMMITTEE ON COUNCILS
960602HOD-IH
DEVELOPMENT OF PRACTICE PARAMETERS FOR BRAIN SPECT
IMAGING IN COOPERATION WITH THE AMA AND
OTHER APPROPRIATE PHYSICIAN SPECIALTY
GROUPS
MOTION:
950212BOT-11
PROPOSED SNM COUNCIL ON CLINICAL TRIALS
MOTION:
941008EC-17
To authorize the Brain Imaging Council to proceed
with all due speed to develop practice parameter
guidelines in cooperation with other medical specialty
groups such as the American Academy of Neurology,
American Psychiatric Association, as well as other
clinical medical societies representing neurosurgery,
geriatrics, internal medicine and the AMA.
To approve the establishment of a Council on Clinical
Trials.
PROPOSED SNM COUNCIL ON CLINICAL TRIALS
MOTION:
To approve the establishment of a Council on Clinical
Trials.
061502
MOTION:
It was moved, seconded and voted to approve the
formal dissolution of the SNM Radioassay Council.
(Resolution, June 15, 2002, Board of Directors) Next
review date 2007.
091402
MOTION:
It was moved, seconded and voted to approve a
second task force with the Committee on Councils to
develop a new model for how councils function in the
new SNM governance structure. The model plan
outline will be delivered at the 2003 Mid Winter
Meeting. (Resolution, September 14, 2002, Board of
Directors) Next review date 2007
012503
MOTION:



It was moved, seconded and voted to approve the
following four (4) Procedure Guidelines:
Procedure Guideline for Brain Death Scintigraphy (New Guideline)
Procedure Guideline for Palliative Treatment of Painful Bone Metastases (Revised
Guideline)
Procedure Guideline for Radionuclide Cystography in Children (Revised Guideline)
28

Procedure Guideline for Pediatric Sedation in Nuclear Medicine (Revised
Guideline)
(Resolution, January 25, 2003, Board of Directors)
Next review date 2008.
060911
MOTION:
060602BOD
MOTION:
Resolved, that the composition of the Committee on
Councils be changed to include a) all council vice
presidents (or president-elect or similar designation)
as members in addition to all council presidents.
b) the chairs (or Presidents or similar designation)
and the vice- hairs (or vice-presidents or similar
designation) of the Centers of Excellence Be it
further resolved, that a vice chair for the Committee
on Councils be appointed from among current
council presidents. Be it finally resolved, that each
Council or Center of Excellence have one vote on the
Committee on Councils.
SNM supports the document "Recommended
Minimal Components of a Resident's Participation
in a Radioiodine Therapy Case" as approved by
the NMPD and the Academic Council
Recommended Minimal Components of a Resident's Participation in a Radioiodine
Therapy Case
1.
Dictation(s) of Patient Evaluation -To include:
A.
B.
C.
D.
E.
2.
3.
4.
5.
6.
7.
Pertinent Medical History and Physical examination
Summary of laboratory and diagnostic studies
Impression confirming diagnosis and appropriateness of therapy
Therapy options presented to patient
Exclusion of pregnancy as appropriate
Document resident’s participation in obtaining informed consent
Document rationale for dose of radioiodine (size/wt of gland for benign disease;
lesion histology, patient age, nodal/extrathyroidal involvement etc for neoplasia)
Resident will complete a written directive that is signed by authorized user
Document Radiation Safety Instructions / Precautions and Other Pertinent
Instructions for Patient.
Verify correct patient and radioiodine dosage, document dose administration,
and the administration of any ancillary drugs (anti-nausea, lithium etc)
Document plans for follow up patient appointment to assess response to
therapy.
29
8.
Program director/authorized user confirms that all items are complete and that
the resident's log indicates satisfactory completion of requirements for a patient’s
radioiodine therapy.
060212HOD
MOTION:
It was moved, seconded and voted that the name of
the Nuclear Oncology Diagnosis and Therapy Council
be changed to the Nuclear Oncology Council.
070218HOD
MOTION:
It was moved, seconded and vote to approve the
new GI Council.
30
COMMITTEE ON EDUCATION
061402
MOTION:
To approve the Curriculum Guide for “Student
Education in Nuclear Medicine.” (Resolution, June
14, 2002, BOD) Next review date 2007
061502
MOTION:
It was moved, seconded and voted to approve the
written curriculum guidelines for student education in
nuclear medicine. (Resolution, June 15, 2002, Board
of Directors) Next review date 2007.
091402
MOTION:
It was moved, seconded and voted to approve
changes to the SNM Procedures realigning the
Committee on Continuing Education, Committee on
HealthCare Policy and Practice, and Committee on
Radiopharmaceuticals under committees monitored
by the BOD. (Resolution, Sept 14, 2002, BOD) Next
review date 2007.
PET Certification
Dr. Maurer discussed that at present there is a need to establish standards for
competency for PET by physicians. The American Board of Nuclear Medicine
(ABNM) is unable to establish a certifying examination in PET. Legally, it would
be best for an independent organization to create a certification program;
certification is not achievable through American Board of Medical Specialties
(ABMS) channels. Dr. Gelfand proposes the establishment of a working group to
fast track an effort to establish what needs to be done, and whether it requires
certification, other evidence of competency or CME credit.
012503
MOTION:
It was moved, seconded and voted to develop a
program on maintenance of competency with
regard to PET education. (Resolution, January 25,
2003, Board of Directors) Next review date 2008.
020614
MOTION:
It was moved, seconded and voted to approve the
Curriculum Guide for Student Education in Nuclear
Medicine.
Fall 2004 SNM Board of Directors Meeting
Cardinal Health Program
Dr. Thakur gave an overview of the Educational Program entitled, Confidence in PET,
which is currently sponsored by Cardinal Health. For the past three years SNM has had
conversations with representatives from Cardinal Health regarding the need for
education in PET and PET/CT for nuclear medicine physicians, radiologists, and referring
31
physicians similar to the Confidence in PET program. Within the infrastructure of the
PET Learning Center programs SNM will incorporate 3 additional training opportunities
to meet this need. The programs will be organized in accordance with ACCME
Essentials and Standards and will be funded by an educational grant from Cardinal
Health. Other industry supporters will be informed of this program and invited to fund
similar educational opportunities. Virginia Pappas stated that the program meets the
SNM guidelines on Commercial Support and that the contract needs to be finalized.
Discussion followed about the need for making an announcement about the program. A
decision was made to not make an announcement until a proposal had been drafted by
SNM and agreed upon by both parties.
MOTION:
There was a motion to approve the Educational
Program. The motion was seconded and voted to
approve an educational program entitled, Confidence
in PET to be funded an educational grant from
Cardinal Health.
MOTION: PET and CT Education Program,Dr. Conti made a
motion for the board to approve a contingency access
of up to $100k from the reserve fund for the education
committee and staff to develop a plan including
program, costs and revenue stream for a CT training
educational initiative by December 2004. Once a plan
is reviewed and approved by the board the intent is to
return the money to the reserves as revenue is
accrued.
MOTION:
The motion was seconded and voted to approve a
budget contingency amount of up to $100,000 for the
development of a program for a CT educational
initiative. The Education Committee is to present a
proposal to the Board at the SNM Midwinter meeting.
070601BOD
MOTION:
It was moved, seconded and voted to endorse the
plan to comply with the MOC Part IV requirement in
developing a project base curriculum to offer the
membership assistance.
070929BOD
MOTION:
It was moved and voted to approve the revised
Continuing Education Mission Statement as amended.
(attached as Appendix 4)
080216BOD
MOTION:
It was moved, seconded and voted to approve the
32
SNM Education Strategic Plan. (Appendix 23)
MOTION:
It was moved, seconded and voted to approve the
SNM MOC Part IV Business Plan. (Appendix 24)
090208BOD
MOTION:
It was moved, seconded and voted to create a
business plan and cost analysis of developing a standalone CT exam. Staff will report back to the board
during the Spring Meeting. In addition, a small task
force will be created to help staff develop the business
plan.
090418BOD
MOTION
It was moved, seconded and voted that the SNM
Board of Directors summarize the Academic Council
comments in a letter to ACGME and include SNM’s
position regarding the current program requirements.
SNM’s position is: Current program requirements are
inadequate for a Program Director to be able to plan a
residency/fellowship program and for an ACGME site
visit reviewer to be able to review the program. SNM
recommends that the Nuclear Residency Program
Requirements be revised using the current ACGME
Nuclear Medicine residency program requirements as a
guide.
33
COMMITTEE ON ETHICS
950212BOT-16
SOCIETY OF NUCLEAR MEDICINE: POLICY ON CONFLICT OF
INTEREST FOR LEADERSHIP AND REPRESENTATIVES
MOTION:
950210EC-02
To endorse the Conflict of Interest Policy & Disclosure
Statement, as presented. The Ethics Committee
recommended that the Conflict of Interest be kept in
the SNM Headquarters for a period of one (1) year.
The Executive Director will act as the gatekeeper of
the Conflict of Interest Statements.
CONFLICT OF INTEREST IMPLEMENTATION PROTOCOL
MOTION:
To approve the current disclosure statement as
presented by the Committee on Ethics in Nuclear
Medicine. APPROVED.
MOTION:
To request that the Committee on Ethics in Nuclear
Medicine develop implementation protocol and record
maintenance. APPROVED.
MOTION:
It was moved, seconded and voted, to approve the
revised Conflict of Interest disclosure form and policy
with the amendments noted above.(Resolution, June
14, 2002, Board of Directors) Next review date
2007.
010622
MOTION:
It was moved, seconded and voted that the SNM
Conflict of Interest Policy, attached, be approved.
(Appendix 35)
020614
MOTION:
2010/0129BOD
MOTION
It was moved, seconded and voted, to approve the
revised Conflict of Interest disclosure form and policy
with the amendments noted below.
The BOD discussed the new form and proposed an amendment whereby the Board of
Directors annually shall have an open review of the non-financial portions of the
disclosure forms of its members and the summary report of potential financial conflicts
prepared by the General Counsel. SNM's General Counsel was directed by the BOD to
work with the Committee on Ethics to develop a procedure on how to handle
compilation of financial disclosure information for the annual GC's report to the board,
as well as a procedure manual implementation of the revised Conflict of Interest Policy.
It was moved, seconded and voted to approve and
34
endorse the CMSS Conflict of Interest Document.
(APPENDIX 36)
2011/0603BOD
MOTION
It was moved, seconded and unanimously voted for
SNM to develop a code of professional conduct,
similar and consistent with that of the CMSS Code for
Interactions with Companies, which will include a
schedule for implementation.
35
COMMITTEE ON FINANCE
960602HOD-07
FINANCIAL SUPPORT FOR VOLUNTEER OFFICERS: SNM
PRESIDENT, JNM EDITOR, OTHER ELECTED
OFFICERS
MOTION: To provide an annual stipend of $20,000 for the SNM
President and an annual stipend of $10,000 for the
SNM President-Elect, beginning with the 1996-1997
SNM Fiscal Year. To provide an annual stipend of
$10,000 for the current SNM President, from the SNM
President Contingency Fund.
960531BOD-13
ANNUAL BUDGETED CONTRIBUTION TO RESERVES
MOTION:
960531BOD-06
To approve a balanced budget for Fiscal Year 1996
1997, including a contribution to reserves of five (5)
percent (%) of budgeted revenue. Future Society
budgets will be balanced with a like contribution to
reserves until total reserves are equal to 50% of
annual budgeted expenses, plus accumulated
depreciation.
FINANCIAL SUPPORT FOR VOLUNTEER OFFICERS: SNM
PRESIDENT, JNM EDITOR AND OTHER ELECTED
OFFICERS.
MOTION:
To provide an annual stipend of $20,000 for the SNM
President and an annual stipend of $10,000 for the
SNM President-Elect, beginning with the 1996-1997
SNM Fiscal Year, if requested by the employer and
paid to the employer.
MOTION:
To provide an stipend of $10,000 for the current SNM
President from the SNM President Contingency Fund,
if requested by the employer and paid to the
employer.
36
960413BOD-17
FINANCIAL SUPPORT FOR VOLUNTEER OFFICERS: SNM
PRESIDENT, JNM EDITOR, OTHER ELECTED
OFFICERS
MOTION:
960413BOD-02
To provide an annual stipend of $20,000 for the SNM
President and an annual stipend of $10,000 for the
SNM President-Elect, beginning with the 1996-1997
SNM Fiscal Year. To provide an annual stipend of
$10,000 for the current SNM President, from the SNM
President Contingency Fund.
REVIEW OF 1995-1996 SNM BUDGET REVISION
MOTION:
To bring the Contingency Fund for the SNM President
back to $25,000 and to reset the funding for the SNM
President's reception at $14,800. APPROVED.
960112BOD-NBF SCHEDULING OF THE ANNUAL SNM BUDGET-PLANNING MEETING
MOTION:
To change the scheduling and structuring of the
annual budget from April to September of each year,
preceding with the Fall Meeting of the Board of
Directors.
960112BOD-NBE FY 1995 SNM, INC. FINANCIAL AUDIT
MOTION:
950610BOD-09
To approve the FY 1995 SNM, Inc. Financial Audit, as
submitted.
1994-1995 AUDIT FIRM
MOTION:
To approve the selection of the firm, Tate & Tryon, to
conduct the SNM Annual audit beginning with Fiscal
Year 1994-1995. [Cf. Bylaws, Article X, Section 2D,
Responsibilities of the Board of Directors: "To manage
the business and financial affairs of the Society in
accord with the policy approved by the House of
Delegates."]
37
950610BOD-07
COMMITTEE ON FINANCE AND BUDGETS
MOTION:
1. To approve the 1995-1996 SNM Budget as
presented by the Committee on Finance & Budgets.
2. To allocate $2,500 to the ARR in a good faith effort
to obtain representation on the ARR Board. The
Society hopes the ACNP, ASNC, ABNM, and other
Nuclear Medicine Organizations will also make a
contribution in order to present an even stronger
financial representation.
950609BOD-NB11995-1996 SNM BUDGET
MOTION:
950408EC-01
To approve the 1995-1996 SNM Budget, as reviewed
and revised.
REPORT OF THE COMMITTEE ON FINANCE & BUDGETS: 1996
RECOMMENDATIONS BY HAROLD ATKINS, M.D.
MOTION:
All classes of members of the Society (only) shall
have their dues increased by 4% for fiscal year 1995
1996, rounded to the nearest $5.
960602
MOTION:
To provide an annual stipend of $20,000 for the SNM
President and an annual stipend of $10,000 for the
SNM President-Elect, if requested by the employer
and paid to the employer, beginning with the 1996
1997 SNM Fiscal Year. To provide an annual stipend
of $10,000 for the current SNM President, if
requested by the employer and paid to the employer,
from the SNM President Contingency Fund.
(Resolution, June 2, 1996, House of Delegates) Next
review date 2001.
010210
MOTION:
It was moved, seconded and voted to require
immediate notification by the Chairman of the Finance
Committee at any point an anticipated Board action is
in conflict with the current Society budget and to
render an assessment of the pending action’s impact
on the Society’s financial standing. It was further
moved that the Finance Committee Chair give a
report to the Board at every meeting on the financial
38
status of the organization comparing current
membership, current state of SNM investments and
reserves and notification of motions coming before
the Board at that meeting which would impact the
Society financial picture.
010929
MOTION:
It was moved, seconded and voted that a formal
policy be established requiring a financial impact
statement on any action taken by any SNM entity
which would have a financial impact on the Society
and/or its budget, and that the statement be
submitted for review by the SNM Committee on
Finance.
020614
MOTION:
It was moved, seconded and voted, that BOD
approve the re-allocation of $25,000 to the SNM
capital budget for these upgrades. (Resolution, June
14, 2002, Board of Directors) Next review date 2007.
020914
MOTION:
It was moved, seconded and approved to institute a
$20 registration increase for physicians, scientists and
industry attendees, as recommended by the Finance
Committee, for 2003 Annual Meeting. (Resolution,
September 14, 2002, Board of Directors) Next review
date 2007.
030125
MOTION:
It was moved, seconded and voted to approve an
increase of $5.00 in SNM dues beginning with the
year 2003-2004, and a process for similar dues
increases every other year. (Resolution, January 25,
2003, Board of Directors) Next review date 2008.
030620
MOTION:
There was a motion to revise the reserve fund line
item for 2004 and future years. It was moved,
seconded and voted to approve including a line item
in the 2003-2004 operating budget transferring .5%
of the operating expense budget to the reserve fund
and increase this line item amount in 2004-2005 and
future year budgets to equal the savings of the
mortgage payments until we reach the reserve fund
goal of 50% of the immediately succeeding years
operating expense, which includes depreciation.
(Resolution, June 20, 2003, Board of Directors) Next
review date 2008.
39
Fall 2004 SNM Board of Directors Meeting
Discussion of the FY 2004-2005 budget included highlights from the Finance Committee
meeting that took place earlier that day. Dr. Murphy reported that included in the
Budget is a transfer of funds to capital fund, a fifteen dollar increase in membership
dues, a $10 - $15 increase in annual meeting registration fees depending on category,
a workforce research study and an increase in the SNMTS management fee to
$780,000.
There was additional discussion regarding the need to create additional educational
programs on CT and PET. Expenses associated with these types of educational
programs were not included in the proposed FY 2004-2005 Budget. It was decided
that the topic would be tabled and discussed later in the meeting during New Business.
2004FALL
MOTION:
050617BOD
MOTION: It was moved, seconded and voted to approve the
draft revision to the Society of Nuclear Medicine
Investment Policy Statement for Managed Corporate
Account (the Long-Term Investment Policy
Statement), attached as (Appendix 5).
050617BOD
MOTION: It was moved, seconded and voted to approve
the adoption of the Short-Term Investment Policy
Statement, attached as (Appendix 6).
050918BOD
There was a motion to approve the overall budget.
It was moved, seconded and voted to approve the FY
2004-2005 Budget. Dr. Murphy asked the BOD to
review the Business plans included in the budget
packet. There was a motion to approve the Councils
Business Plans respective of budget. It was moved,
seconded and voted to approve the Business Plans
presented by the SNM Councils.
MOTION: It was moved, seconded and voted to rescind the
2003 Capital Investment Funding Policy Resolution.
The Finance Committee should consider a contingency
plan and planned investment fund going forward.
MOTION: It was moved, seconded and voted to approve the
Reserve Spending Policy (Appendix 25)
with a revision to the last sentence of the first
paragraph of the third page to read: “If this 30%
minimum level is not achieved, no discretionary
spending may take place.
40
060211BOD
MOTION:
Resolved, that the Board of Directors re-designate
$238,000 from the Capital Fund to be used as a
contingency fund to be increased each year by 50%
of the investment returns as measured by the
audited year-end financial statements. The
mechanisms for spending these funds will be
developed by a task force who will present the
Contingency fund usage policy and guidelines at the
April Board of Directors meeting.
060424BOD
MOTION: Resolved, that the Board of Directors adopt the
following spending policy for the Contingency Fund:
Approval for spending moneys from the Contingency
Fund must be obtained from the executive committee
in writing prior to it being spent. This would include
amounts of money up to $25,000. Any amount of
money above $25,000 would need full majority board
approval.
Requests for expenditures less than $25,000 must be
submitted to the executive committee for discussion
and vote prior to the money being committed. These
requests should be in keeping with the strategic plan
of the society and help the president be more nimble
and augment faster decision-making necessary to
accomplish the goals of the strategic plan.
A full monthly accounting of the fund will be
reported in the monthly financials. This will include
commitments made, amounts spent, the vendor, and
the purpose of the payment.
Any money not spent in a year would go into the
Capital Fund. The Contingency Fund will be funded
every year with any amount in the Capital Fund over
30% of the next year's operating expense budget, up
to a maximum of $200,000. There will be a limit of
funds available in the Contingency Fund of $200,000
annually.
060601BOD
MOTION:
Resolved, that the Board of Directors approve
spending under the Contingency fund to engage
McKinley Marketing to assist SNM with the branding
process. They will use focus groups, surveys, and
interviews to help SNM re-brand in the field of
41
molecular imaging and therapy.
060910BOD
070217BOD
080216
MOTION:
It was moved, seconded and voted approve the JM
Institutional Subscription Rate effective for FY2008 be
increased a total of 25% above the FY2006 rate.
MOTION:
Resolved, that the Board approve that SNM not send
the abstract books to the pre-registrants for the
Annual Meeting.
MOTION:
Resolved, that the Finance Committee
recommends that any additional work requested of
the independent auditors beyond the audit and tax
return filings be approved by the Board of Directors.
MOTION:
Resolved, that the Finance Committee recommends
approval of the CEO’s and the President’s Travel and
Expense Reports by the Treasurer on a quarterly
basis.
MOTION:
Resolved that the Finance Committee recommends
the SNM Board of Directors approve the increase of
the dues for full members from $260.00 to $275.00.
MOTION:
It was moved, seconded and voted to change the
target and range percentages as presented in Section
III.D. for two asset classes to: Asset Class Target
Range Domestic Equities45% (55%) 30 - 70% (40 –
70%) International Equities 15% (5%) 0 - 20% (0 –
10%)
MOTION:
080614BOD
MOTION:
It was moved, seconded and voted to approve that
Foreign Bonds and the appropriate benchmark to the
Asset Class shown in Section IV be added to the
Investment Policy. These investments will be held as
bond mutual funds, but subject to the target and
range limits stated for Fixed Income Securities.
It was moved, seconded and voted that SNM select
the independent audit firm of McGladrey & Pullen to
audit the financial statements of SNM, Inc. for the
years ended September 30, 2008, 2009 and 2010
provided that the firm match the fee submitted by a
competitor during the bidding process and rotate the
proposed audit partner.
42
080614BOD
MOTION:
It was moved, seconded and voted that the SNM
Committee on Finance work with SNM Leadership to
develop a long-term funding strategy that will sustain
the society’s molecular imaging initiatives once the
initial Corporate and ERF campaign commitments are
depleted. This funding plan should be presented at the
2009 Annual Meeting.
090208BOD
MOTION It was moved, seconded and voted that the SNM
Board of Directors accept the Society of Nuclear
Medicine, Inc. audited Financial Report for September
30, 2008 as audited by McGladrey & Pullen.
090612BOD
MOTION It was moved, seconded and voted that the
SNM/SNMTS management fee for fiscal years 2010 and
2011 be fixed at the amount budgeted for fiscal year
2009 of $1,094,637.
It was moved, seconded and voted that the SNMTS
Mid-Winter Meeting stipend be set at $80 per each
paid SNMTS member and non-member technologist
registrant to the 2010 and 2011 MWM.
It was moved, seconded and voted that the CEO of
SNM be authorized to enter into a computer
equipment lease arrangement on behalf of SNM in
order to comply with lending requirements of BB&T
Equipment Finance Corporation.
It was moved, seconded and voted that Section III D.
of the SNM Investment Policy Statement be changed
to add Commodities Funds (mutual funds and
exchange-traded funds) to the list of allowed asset
classes with a target and range of 0-5%. Further
resolved that Section III D. of the Investment Policy
Statement be changed to specify a range as the
Target replacing the fixed percentage Target now
presented.
Target
Domestic Equities 40-45% from 45%
International Equities 12-16% from 15%
Fixed Income Securities36-41% from 40%
Commodities Funds 0-5% from Short-term Investments 0-5% from 0%
43
Further resolved that Section III E. of the SNM
Investment Policy Statement be changed to strike the
wording which currently doe not allow commodity
transactions. Further resolved that Section IV. Of the
Investment Policy Statement be changed to add
commodities funds to the asset classes, with the
benchmark index to be the Dow Jones – AIG
Commodities Index.
2010/0604BOD
MOTION
It was moved, seconded and voted to amend the
investment policy as follows:
1. Section III D. - add Real Estate Funds to the list of
allowed asset classes, with a “Target” and a Range of
0-5%.
2. The “Target” for Domestic Equities and Fix Income
Securities asset class in Section III D. of the SNM
Investment Policy Statement be changed as follows :
Domestic Equities
Fixed Income
Securities
Target
4047%
3339%
From
4045%
3641%
3. Section IV. - add Real Estate Funds to the allowed
asset classes, with the Benchmark index to be the Dow
Jones – All Equity REIT Index.
It was moved, seconded and voted that the SNM
Subcommittee on Investments will request proposals
from investment advisors at least every five years,
sooner if performance warrants. The subcommittee’s
review of proposals will include no less than three
qualified investment advisors.
2011/0603BOD
MOTION
It was moved, seconded and unanimously voted that
the SNM Board of Directors accept the
recommendation of the audit subcommittee to
reappoint the CPA firm of McGladrey & Pullen to a
three-year term as independent auditor of SNM’s
financial statements.
It was moved, seconded and voted that the allocation
methodology for determining the SNM/SNMTS
management fee for fiscal year 2012 be changed to
44
that recommended by the SNM/SNMTS Management
Fee Task Force.
2011/0603BOD
MOTION It was moved, seconded and unanimously voted that
the Center for Molecular Imaging Innovation and
Translation be permitted to carry over funds from year
to year up to $25,000.
It was moved, seconded and unanimously voted that
the Center for Molecular Imaging Innovation and
Translation be permitted to carry over funds from year
to year up to $25,000.
It was moved, seconded and unanimously voted that
the Center for Molecular Imaging Innovation and
Translation be permitted to carry over any remaining
Molecular Imaging Campaign funds into its budget for
FY2012 and FY2013 to be used for CMIIT staffing and
programs.
2012/0429BOD
MOTION It was moved, seconded and unanimously voted to
approve management’s recommendation to open a
bank account for the new FSA with SNM’s CEO and
CFO as signatories on the account.
45
COMMITTEE ON GUIDELINES AND COMMUNICATION
010623
MOTION:
It was moved, seconded and voted that the following
procedure guidelines be adopted:
1. Procedure Guideline for C-14 Urea Breath Test
2. Procedure Guideline for Gallium Scintigraphy in
the Evaluation of Malignant Disease
3. Procedure Guideline for Hepatobiliary
Scintigraphy
4. Procedure Guideline for Guideline Development
5. Procedure Guideline for the Use of
Radiopharmaceuticals
(Resolution, June 23, 2001, House of Delegates) Next
review date 2006.
010210
MOTION:
It was moved, seconded and voted to approve the
SNM Procedure Guideline for Somatostatin Receptor
Scintigraphy.
020614
MOTION:
It was moved, seconded and voted to approve four
procedure guidelines as listed below:
 Procedure Guideline for Gated Equilibrium
Radionuclide Ventriculography
 Procedure Guideline for Myocardial Perfusion
Imaging
 Procedure Guideline for TeleNuclear Medicine

Procedure Guideline for Lymphoscintigraphy
and the Use of Intraoperative Gamma Probe for
Sentinel Lymph Node Localization in Melanoma of
Intermediate Thickness.
(Resolution June 14, 2002, Board of Directors)Next
review date 2007
020615
MOTION:
It was moved, seconded and voted to approve the
Procedure Guideline for Gated Equilibrium
Radionuclide Ventriculography, Procedure Guideline
for Mycardial Perfusion Imaging, Procedure Guideline
for TeleNuclear Medicine and Procedure Guideline for
Lymphoscintigraphy and the Use of Intraoperative
Gamma Probe for Sentinel Lymph Node Localization in
Melanoma of Intermediate Thickness as written.
(Resolution, June 15, 2002, BOD) Next review 2007
FALL 2004 SNM BOARD OF DIRECTORS MEETING
46
FALL 2004
MOTION:
Dr. Thakur reported that the Procedure Guidelines
were presented at the June board meeting. The
board is asked to approve the following revised
guidelines: Parathyroid Scintigraphy, General
Imaging, Breast Scintigraphy, Tc99m Examentazime,
labeled Leukocyte Scintigraphy, In-111 Leukocyte
Scintigraphy for Suspected Infection/Inflammation,
Gallium Scintigraphy for Suspected
Infection/Inflammation and LungScintigraphy. He
reported that Pediatric is still in review.
FALL 2004
MOTION
There was a motion to approve the Procedure
Guidelines revisions. The motion was seconded and
voted to approve the guidelines.
070601BOD
MOTION:
It was moved, seconded and voted to approve the
Procedure Guideline for the Use of
Radiopharmaceuticals v3.3. (APPENDIX 7)
090208BOD
MOTION: It was moved, seconded and voted that to approve
the existing combined guidelines in current format,
and send a letter to ACR stating approval of the
guidelines along with a request that ACR and SNM
continue to work together with the ultimate goal of
having a single document coming from both
ACR/SNM.
It was moved, seconded and voted to approve and
adopt the five ACR/SNM 2009 Scintigraphy Practice
Guidelines: Pulmonary Scintigraphy in Adults and
Children, Thyroid Scintigraphy and Uptake
Measurements, Scintigraphy for Inflammation and
Infection, Cardiac Scintigraphy, and Pulmonary
Scintigraphy.
It was moved, seconded and voted to approve the
Procedure Guideline for FDG-PET Brain Imaging,
version (3.0).
47
COMMITTEE ON HEALTH CARE POLICY & PRACTICE
951021BOD-03
SNM COMMISSION ON HEALTH CARE POLICY
MOTION
950610BOD-06
To approve proposed new activities of the
Commission on Health Care Policy, as identified
above.
DISSOLUTION OF THE SOCIOECONOMIC COMMITTEE
MOTION:
To recommend that the SNM Socioeconomic
Committee be dissolved and the functions of the
Committee not being performed by other society
activities be transferred to the Commission on
Practice.
960114
MOTION:
To approve the Proposed Nuclear Medicine Procedure
Guidelines Reviewed and Approved by the SNM
Commission on Health Care Policy (CHCP) and
reviewed during Reference Committee Hearings at the
1966 SNM Mid-Winter Meeting, with the exception of
the guideline on pediatric sedation. (Resolution,
January 14, 1996, House of Delegates) Next
review date 2001.
980201
MOTION: Review and approval of the Performance and
Responsibility Guidelines for the Nuclear Medicine
Technologist as revised.
The Performance and Responsibility Guidelines for the Nuclear
Medicine Technologist (1998 revision) submitted by Kathy Thomas,
CNMT, President of the SNMTS and the SNM Practice Management
committee. (Resolution, February 1, 1998, House of Delegates)
Next review date 2003.
020914
050918BOD
MOTION:
It was moved, seconded and voted to approve
changes to the SNM Procedures realigning the
Committee on Continuing Education, Committee on
HealthCare Policy and Practice, and Committee on
Radiopharmaceuticals under committees monitored
by the BOD. (Resolution, September 14, 2002,
Board of Directors) Next review date 2007.
MOTION: It was moved, and voted to update the SNM
48
1.
2.
3.
4.
5.
government relation’s list of priorities to the
following:
DOE Issues
a. DOE funding for basic nuclear medicine research
b. National Radionuclide Production Enhancement (NRPE)
program.
NRC Issues
a. Energy Policy Act
b. General Outreach
FDA Issues
a. Continuing solid relations
b. Broaden the scope of the FDA NM coalition beyond FDA
issues
Increasing the sales of the Phantom Program (pursue contract
with Dept. of Defense)
a. Medical training/Residence Issue
SHPLs (further establishing a grassroots network)
It was further decided that a task force would review
the medical training/residency issues and recommend
policy and course of action to the Government
Relations committee.
050918BOD
MOTION: It was moved, seconded and voted that SNM
develop specific clinical guidelines/indicators
for use in pay for quality performance. The SNM
should work with other organizations where
possible when developing these guidelines/
indicators.
Be it further, resolved that the HCPP committee
form a subcommittee to develop these indicators and
report back with a draft by November 1, 2005.
MOTION: It was moved, seconded and voted that the SNM
develop new or revised CPT codes that correctly
reflect the resource utilization when PET and
diagnostic CT are performed at the same time.
MOTION:
It was moved, seconded and voted that SNM
develop a cadre of physicians and educational
programs that promotes accurate completion of
UC surveys. Board members and key committee
chairs be included in this cadre.
49
Be it further, Resolved, that the HCPP committee
develop a subcommittee to work on this project
and also work closely with the ACNP on
implementation.
060211BOD
060602BOD
MOTION:
It was moved, seconded and voted to communicate
to ICANL the need for increased emphasis on
general nuclear medicine services and the
marketing of ICANL programs. Should ICANL be
unwilling or unable to fulfill this need, the SNM
should explore other alternatives to meet this
demand.
MOTION:
The Committee recommends to the BOD that the
SNM support the coalition being formed to reverse
the imaging reductions contained in the 2005 Deficit
Reduction Act. This support should be limited to the
use of the SNM’s name only until such time as we
have further data on the cost of private practice
exams versus the APC cost. Further, the Committee
suggests reserving future support until the nature
and content of the proposed technical amendment is
available for review.
MOTION:
Given the increasing demand for practice
accreditation in the third-party payer community and
concerns for continuing patient safety, the
Committee recommends to the BOD that the SNM
support mandatory/compulsory accreditation by a
recognized accrediting body.
MOTION:
The Committee recommends to the BOD that,
pending the approval of the revised Myocardial
Perfusion Imaging Guideline by the SNM Guidelines
Committee, the BOD adopt this guideline as a draft
document and share it with the other concerned
nuclear medicine organizations for further refinement
and the development of a consensus guideline.
MOTION:
The Committee recommends to the BOD that the
SNM remain an active participant in the Access to
Medical Imaging Coalition but not contribute
anything financially to the coalition, thus forfeiting
voting rights.
50
070217BOD
MOTION: The SNM Health Care Policy and Practice Committee
recommends that the SNM BOD accept the proposed
radiopharmaceutical reimbursement methodology
based on invoice pricing as presented in the attached
document and direct that SNM representatives
present to CMS this methodology.
MOTION: The SNM Committee on Health Care Policy and
Practice recommends to the SNM BOD that the SNM
continue as a member of the Access to Medical
Imaging Coalition. However, should an issue arise
where we do not agree with the position of AMIC,
the committee recommends that the SNM BOD
retain the option to request removal of the Society’s
name from the position paper.
080216BOD
MOTION:
The SNM Committee on Health Care Policy and
Practice recommends that the SNM BOD establish
with the SNMTS Leadership a joint task force
composed of nuclear medicine technologists,
pharmacists, and physicians to develop medication
management and reconciliation processes that meet
the existing regulatory expectations for adjunctive
medications used in nuclear medicine. Further, the
committee recommends that the matter of
medication management and reconciliation be
communicated to membership immediately as this
could have potential impact on nuclear medicine
departments.
MOTION:
The SNM Committee on Health Care Policy and
Practice recommends that the SNM BOD form a
group to work on developing a methodology and
data to support an impact factor that can be used for
advocacy.
MOTION:
It was moved, seconded and voted that the SNM
Practice Standards Committee and PET Utilization
Task Force be charged with developing the next
guideline to be used for physician performance
measures.
MOTION:
It was moved, seconded and voted that SNM commit
to developing guidelines oriented towards what
constitutes good physician performance in imaging
51
specialties.
090208BOD
MOTION:
It was moved, seconded and voted that the SNM
Board of Directors approve the
ACCF/ACR/AHA/ASE/ASNC/HRS/NASCI/RSNA/
SAIP/SCAI/SCCT/SCMR 2008 Health Policy
Statement on Structured Reporting in Cardiovascular
Imaging.
090727BOD
MOTION:
It was moved, seconded, and unanimously voted
that the SNM adopt the following position related to
legislative proposals to increase the practice
expense imaging equipment utilization rate
assumption. “SNM opposes proposed increases to
the practice expense imaging equipment utilization
rate assumption and urges CMS to conduct research
into actual utilization rates, particularly in rural
areas, for imaging on which to base any change.“
It was moved, seconded, and unanimously voted
that the SNM adopt the following language as the
official SNM position on the separate payment
categories: SNM opposes the creation of any system
that attributes the reimbursement for imaging
services rendered to a separate imaging category or
“bucket.” Instead, the reimbursement costs
associated with imaging procedures should always
be attributable to the specialty to which the
referring physician belongs. For example, imaging
done and/or ordered by a neurologist should be
attributed to the neurology bucket.
It was moved, seconded, and unanimously voted
that the SNM adopt the following position related to
the Stark ancillary in-office exception. “(1) SNM
supports no change at this time in the ancillary inoffice exception. (2) SNM recognizes there is
concern about inappropriate use of the exception
and therefore recommends increased transparency
by requiring that physicians disclose to their patients
their financial interest in certain imaging services
provided through the in-office ancillary services
exception and requiring referring physicians to
inform patients in writing (at the time of referral)
that the patient can obtain imaging services from
52
other entities, and provide to the patient a written
list of other entities within a 20-mile radius of the
imaging facility capable of providing the services.”
2010/0418BOD
MOTION
It was moved, seconded and voted that the SNM
Board of Directors approve and accept the following
statement dose reduction; It is the position of SNM
that patient exposure to ionizing radiation should be
at the minimum level consistent with obtaining a
diagnostic examination. Reduction in patient
radiation exposure may be accomplished by
administering less radiopharmaceutical when the
technique or equipment used for imaging can
support such an action. Each patient procedure is
unique and the methodology to achieve minimum
exposure while maintaining diagnostic accuracy
needs to be viewed in this light.
Radiopharmaceutical dose ranges outlined in this
document should be considered as a guide. Dose
reduction techniques should be utilized when
appropriate. The same principles should be applied
when CT is used in a hybrid imaging procedure. CT
acquisition protocols should be optimized to provide
the information needed while minimizing patient
radiation exposure.
53
COMMITTEE ON NOMINATIONS
960114HOD-NCC NOMINATIONS SLATE OF CANDIDATES
MOTION:
To accept the slate of candidates submitted by the
Subcommission on Nominations.
950212BOT-NCC NOMINATING COMMITTEE
MOTION:
To endorse of the slate of candidates on the Ballot.
54
COMMITTEE ON PUBLICATIONS
960112BOD-PCR JOURNAL OF NUCLEAR MEDICINE
MOTION:
941008EC-16
That the Publications Committee consider an editorial
change in the format of the JNM, requiring the
content to be formulated as acceptable for outcomes
analysis work and in a format similar to other medical
journals.
PROPOSED SNM NEWSPAPER
MOTION:
To endorse the "Recommendations of the Publications
Committee on the Feasibility of a Society-Wide
Newspaper".
After discussing the report, the Executive Committee
ratified the following recommendations outlined in the
Report of the Publications Committee
Recommendation #1:
The Society should sponsor a Reference Committee
Hearing for a potential Society Newspaper at the
1995 SNM Midwinter Meeting;
Recommendation #2:
The Executive Committee and the Committee on
Finance & Budgets should assess the financial impact
of any Society Newspaper;
Recommendation #3:
Results of the Reference Committee Hearing will be
reviewed by the Publications Committee with a final
recommendation to the Board of Trustees
960114HOD-04
PUBLIC RELEASE OF POLICY STATEMENTS, POSITION PAPERS,
ETC. DEVELOPED BY SNM ORGANIZATIONAL COMPONENTS
MOTION:
Organizational components of the SNM are
empowered to submit manuscripts to the JNM or the
JNMT directly, as long as such manuscripts are
simultaneously submitted to the Board of Directors.
APPROVED. Organizational components of the SNM
are empowered to submit manuscripts to the JNM or
the JNMT directly, as long as such manuscripts are
55
simultaneously submitted to the Board of Directors.
(Resolution, January 14, 1996, House of Delegates)
Next review date 2001.
010210
MOTION:
It was moved, seconded and voted that all existing
policies prohibiting the inclusion of staff time,
overhead and other legitimate direct or indirect costs
in the costing and pricing of SNM publications shall be
revoked.
020209
MOTION:
It was moved, seconded and voted to use a tag line
emphasizing molecular imaging with the current SNM
name. (Resolution, February 9, 2002, Board Of
Directors) next review date 2007.
030621
MOTION:
It was moved, seconded, and voted that the Board
authorize acceptance of online advertising in JNM
under the purview of the JNM Editor following the
same management policies as print advertising.
(Resolution, June 21, 2003, Board of Directors) Next
review date 2008.
030621
MOTION:
It was moved, seconded, and voted that the SNM
Board not approve the acceptance of online
sponsorships and advertising on www.snm.org
pending further investigation. (Resolution, June 21,
2003, Board of Directors) Next review date 2008.
FALL 2004 SNM BOARD OF DIRECTORS MEETING
Virtual Journal - Dr. Thakur gave the background information regarding Virtual Journal.
Roberta Arnold of RSNA approached SNM about participation in a virtual journal of
molecular imaging. The board asked the Publications Committee to consider the issue
and provide input. The Publications Committee recommended that SNM not participate
in this effort. Dr. Royal indicated that he is in favor of accepting the recommendation
from the Publications Committee.
FALL 2004
MOTION:
Dr. Conti made a motion that in light of NIH’s Open
Access initiative, the issue be tabled for the time
being. After NIH decides on its course of action, the
Publications Committee should reconsider the issue
and make a new recommendation to the board. The
motion was seconded and voted to table discussion of
the Virtual Journal until the Open Access issue is
resolved.
56
Open Access
Dr. Thakur explained the issue of Open Access. The current NIH initiative proposes
that the public be able to access online, free of charge, any article from any scientific,
technological or medical (STM) journal that discusses the results of research funded by
NIH. All articles would be made available on the PubMed Central database six months
after original publication. Dr. Thakur expressed some of his concerns, noting that Open
Access has more negatives than positives. A draft letter has been prepared from Dr.
Thakur addressed to NIH expressing SNM’s position. There was agreement from the
board to send the letter.
FALL 2004
MOTION:
There was a motion to send the letter to NIH. It was
seconded and voted to send a letter to NIH
expressing SNM’s position on the Open Access issue.
060602BOD
MOTION:
It was moved, seconded and voted that SNM create a
licensing structure for its journals and hire a
consultant to undertake the scope of work described
in the proposal.
MOTION:
It was moved, seconded and voted that SNM
provide open access to JNM and JNMT 12 months
after the date of publication.
070531BOD
It was moved, seconded and voted to approve the
JNM Mission Statement as follows: The Journal of
Nuclear Medicine advances the knowledge and practice of molecular imaging and
therapy and nuclear medicine to improve patient care through publication of original
basic science and clinical research. JNM is a monthly, peer-reviewed journal published
both in print and online by SNM, an international, multidisciplinary professional
organization for molecular imaging and therapy and nuclear medicine professionals.
070601BOD
MOTION:
MOTION:
It was moved, seconded and voted to extend the
JNM Editor term for 2 years ending in December
2010 with his term being consecutive starting with
his current term.
070929BOD
MOTION: It was moved, seconded and voted to approve that
all guidelines be published in the JNMT and at the
discretion of the JNM editor, a short summary be
published in Newsline.
080216BOD
MOTION: It was moved, seconded and voted that SNM’s
journal articles be openly available to the public 6
months after print publication.
57
MOTION: It was moved, seconded and voted that the Journal
of Nuclear Medicine (JNM) move to full color
printing, with no increase in SNMTS expenses to offset the cost.
080614BOD
MOTION:
It was moved, seconded and voted that the
estimated net cost of converting the JNM to full
color of $198,410, as estimated by the Publications
Committee, be funded as follows:
1. $20 per year dues increase for the SNM Inc. Members
(approximately $94,000 of additional revenue)
2. 5% increase on the 2009 institutional subscribers
subscription rate (approximately $40,000 of additional
revenue)
3. That the Publications Committee be responsible for
identifying and supporting implementation of business
activities that will generate the remaining revenue
needed to fully fund the costs of conversion
(approximately $64,410)
58
Committee on Pharmacopeia
080215BOD
MOTION:
It was moved, seconded and voted to charge the
Committee on Pharmacopeia with formulating a
set of recommendations to amend 797 to be
more adaptable to the nuclear medicine
community.
090208BOD
MOTION:
It was moved, seconded and voted to approve
the Proposed Revisions for USP Monograph on
Ammonia N13 Injection.
2010/0129BOD
MOTION
It was moved, seconded and voted to approve the
Sodium Acetate (1-11C) Injection Monograph.
(APPENDIX 37)
2010/0604BOD
MOTION
It was moved, seconded and voted that the SNM
Board of Directors approve the document “Use of
Compounded Radiopharmaceuticals and Adjunct
Drug Preparations.” (Appendix 38)
59
Committee on Radiopharmaceuticals
2011/0121BOD
MOTION
It was moved and unanimously voted to approve
the document: “Recommendations for BeyondUse Dates (BUD) for Tc-99m
Radiopharmaceuticals.” (APPENDIX 39)
60
COMMITTEE ON SCIENTIFIC PROGRAM
960413BOD-10
950609BOD-11
POSITION OF GENERAL PROGRAM CHAIRMAN
MOTION:
To appoint Paul H. Murphy, Ph.D. for an additional
two (2)-year term as General Program Chairman.
MOTION:
To revise the PROCEDURES to establish staggered
terms of office, each two (2) years in length, for the
position of General Program Chairman and Scientific
Program Chairman, with the understanding the
individual appointed to each position will serve one
(1)-year as Chairman-Elect with the current
Chairman.
MOTION:
To revise the PROCEDURES to make the terms of
these two chairmanship effectively three (3) years in
length. The Chairperson of the Scientific Program
Committee and the General Program Chairman will be
named as Chairperson-Elect for a one (1)-year period
along with the current Chairman, followed by a two
(2)-year term of office as Chairman of Scientific
Program Committee or General Program Chairman,
on an overlapping basis with the General Program
Chairman.
APPOINTMENT OF SCIENTIFIC PROGRAM CHAIRMAN-ELECT
MOTION:
To approve the appointment of William C. Eckelman,
Ph.D. as Scientific Program Chairman-Elect for a
second term as Chairman, Scientific Program
Committee. APPROVED. It was moved, seconded and
defeated to add Scientific Program Chair as an
ex-officio member of the Board of
Directors.(Resolution, June 14, 2002, Board of
Directors) next review date 2007.
070217BOD
MOTION: Be it resolved that the abstract book be sent to the
Annual Meeting pre-registrants prior to the Annual
Meeting. (Retraction to Finance Committee Motion
09-10-2006)
070601BOD
MOTION:
It was moved, seconded and voted that the Policy
on Stipends at SNM Mid- Winter Symposium will be
changed to establish the payment of stipends as
61
follows: Funds in the amount of 7500 will be set
aside for council stipends each year for the next
three years beginning with the 2008 SNM MidWinter Education Symposium. The Committee on
Councils will determine how these funds shall be
dispensed among councils participating in the MidWinter Educational Symposium. This policy will be
re-evaluated after 3 years.
2012/0429BOD
MOTION
It was moved, seconded and unanimously voted to
approve Alan Packard, PhD as the General Program
Chair-Elect (term starting June 2012).
2012/0429BOD
MOTION
It was moved, seconded and unanimously voted to
approve Satoshi Minoshima as the Scientific
Program Committee Chair-Elect (term beginning
June 2012).
62
Comparative Effectiveness Research
090208BOD
MOTION:
It was moved, seconded and voted to support
a strategic evaluation and the development of a
cost-effectiveness model for using PET/CT in
recurrent colorectal cancer patients.
63
ELECTIONS
950611BOT-AP
APPOINTMENTS FOR 1995-1996
MOTION:
960602HOD-02
To approve the 1995-1996 SNM Committee
appointments submitted by Peter T. Kirchner, M.D.,
SNM President-Elect.
ELECTION OF DIRECTORS-AT-LARGE TO SERVE ON THE SNM
BOARD OF DIRECTORS
The following were elected to the SNM Board of Directors as
Directors-At-Large:
Robert F. Carretta, M.D.
[3-year term of office]
B. David Collier, M.D.
[2-year term of office]
James J. Conway, M.D.
[3-year term of office]
Gary L. Dillehay, M.D.
[1-year term of office]
William C. Eckelman, Ph.D. [2-year term of office]
Miriam K. Miller, CNMT
[3-year term of office]
Ronald K. Tikofsy, Ph.D.
[1-year term of office]
960114HOD-05
ELECTION OF DIRECTORS AT LARGE; IDENTIFICATION OF
AGENDA TOPICS FOR MEETINGS OF THE HOUSE OF DELEGATES
On behalf Dr. Croll, who had to leave the meeting
earlier, Dr. Murphy presented the agenda topic on the
forthcoming election of Directors-At-Large, which was
referenced earlier by Dr. Croll in his report.
Dr. Murphy announced that eight (8) members of the
House of Delegates were selected by lot, to form the
Nominating Committee of the House of Delegates:
Two (2) were selected from the 14 SNM Regional
Chapters:
Judith Joyce, M.D., Pittsburgh Chapter
Kevin Donohoe, M.D. New England Chapter
Two (2) were chosen from the 12 Council Delegates:
Hani Nabi, M.D., Clinical Trials Council
B. David Collier, M.D., Correlative Imaging
Council
Four (4) were selected from the 28 Delegates-At
Large:
64
I. Ross McDougall, Ph.D., Northern California
Alan D. Waxman, M.D., Southern California
Gary L. Dillehay, M.D., Central
Martin P. Sandler, M.D., Southeastern
030913
MOTION:
It was moved, seconded and voted to approve the
concept of on-line voting beginning in the 2003-04
election. (Resolution, September 13, 2003, Board of
Directors) Next review date 2008.
65
GOVERNMENT / PUBLIC RELATIONS
960602HOD-06
ACNP/SNM GOVERNMENT RELATIONS OFFICE
MOTION:
960531BOD-03
To endorse the SNM Board of Directors to respond to
the upcoming [June 4, 1996] American College of
Nuclear Physicians (ACNP) Board of Regents (BOR)
decisions regarding the ACNP/SNM Government
Relations Office. The House of Delegates directs the
Board of Directors to develop strategic plans and
budgets for the government relations program and
report back to the House of Delegates at its next
meeting.
GOVERNMENT RELATIONS OFFICE CONTRACT WITH MINTZ,
LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, P.C.
MOTION:
WHEREAS the ACNP/SNM Government Relations
Committee endorsed the extension of the contract
with Mintz, Levin, et.al., for a period of six (6) months,
beginning August 1, 1996, primarily for the services
of Alvin J. Lorman, Esq. as counsel to the Government
Relations Office.
BE IT RESOLVED THAT the SNM Board of Directors
approve a six (6)-month extension of the contract
with Mintz, Levin, et.al., primarily for the services of
Alvin J. Lorman, Esq. as counsel to the Government
Relations Office.
960531BOD-02
ACNP/SNM GOVERNMENT RELATIONS OFFICE
MOTION:
The Board of Directors desires the endorsement of
the House of Delegates to respond to the upcoming
[Tuesday, June 4, 1996] American College of Nuclear
Physicians (ACNP) Board of Regents (BOR) decisions
regarding the ACNP/SNM Government Relations
Office. Such endorsement concerns Board of
Director’s direction to both the Committee of
Government Relations and the Committee on Finance
to develop strategic plans and budgets in response to
various ACNP alternatives.
951021BOD-NB1 SECRETARIAL SUPPORT FOR GOVERNMENT RELATIONS
COMMITTEE CHAIRMAN
66
MOTION:
951021BOD-09
ACNP/SNM JOINT GOVERNMENT RELATIONS OFFICE
MOTION:
950408EC-02
To deny additional funding for secretarial support in
her roles as Chairman, ACNP/SNM Committee on
Government Relations: $1,000.00/month for
secretarial assistance.
The funding level from the Society for its 1995-1996
Fiscal Year for the ACNP/SNM Government Relations
Office will remain unchanged.
ACNP/SNM WASHINGTON, D.C. OFFICE
MOTION: SNM will endorse an open forum with FDA. APPROVED.
941008EC-13
ACNP/SNM JOINT GOVERNMENT RELATIONS OFFICE REQUEST
FOR PROPOSAL (RFP)
MOTION:
The Executive Committee unanimously endorses a
paradigm shift in the way the ACNP/SNM Joint Office
approaches Government Relations. The SNM wishes
to add a legal arm to the strategic and tactical
planning of the attainment of its goals. The addition
of legal advice and implementation of action items
should be added to the management of the RFP for
the Joint Government Relations Program.
The Executive Committee also reviewed the Proposal
for a Joint Government Relations Committee in the
context of integrating activities on a vertical basis
with the ACNP and approved the proposal.
MOTION:
960413BOD-04
SNM PUBLIC RELATIONS FRAMEWORK WORK PLAN
MOTION:
960112BOD-04
To approve the proposal for an SNM/ACNP Joint
Government Relations Committee.
To support this program as submitted directed toward
Oncologists, with funding to be addressed at the next
meeting of the Board of Directors.
PUBLIC RELATIONS CENTENNIAL
MOTION:
To allow Committee on Public Relations to conduct a
67
fund raising activity directed towards membership,
affiliated organizations and industry.
951021BOD-11
APPROVAL OF SNM PUBLIC RELATIONS POLICY GUIDELINES
MOTION:
951021BOD-12
SNM CENTENNIAL PUBLIC RELATIONS PROGRAM
MOTION:
941008EC-18
To table final approval of the "Society of Nuclear
Medicine Public Relations Policy Guidelines," pending
review and revision of paragraphs A(1), A(4) and B
based upon the ACNP/SNM Statement of collaboration
and cooperation referenced by Dr. Kirchner in his
report.
To approve activities connected
with celebration of the "Discovery
of Radioactivity Centennial," including seeking outside
(non-corporate) grant funding, and to endorse the
theme of the Centennial, "Nuclear Medicine: 100
Years in the Making."
RBRVS UPDATE STUDY FINAL REPORT
The Executive Committee reviewed the September,
1994 Confidential Executive Summary of the Harvard
RBRVS Study submitted by Kenneth A. McKusick,
M.D. After considering the document at length, the
Executive Committee recommended that Dr. Conway
confer with Dr. McKusick regarding promulgation to
the membership.
It was moved, seconded and voted that the House of
Delegates approve the recommendations of the
NRC Task Force with the inclusion of the following
statement:
“The SNM firmly believes that demonstrated competence in nuclear science should be
the basis for education, training and experience criteria, and it lists the parts 35.290,
.292, and .390, and the NRC should not define the criteria used to determine clinical
competence in the diagnostic and therapeutic uses of radiopharmaceuticals and believe
that such clinical training and competence criteria are best defined by relevant medical
specialty organizations such as the ACGME-approved training programs and the ABMS
sanctioned certifying boards.” (Resolution, June 7, 1998, House of Delegates) next
review date 2003.
68
030125
MOTION:
It was moved, seconded and voted to approve the
project under the stipulation that funding to be
identified comes from outside the SNM, and project
is budget neutral for SNM, Inc. (Resolution, January
25, 2003, Board of Directors) Next review date 2008.
060910BOD
MOTION: It was moved, seconded and voted to approve the
comments to 10 CFR Part 20, 30, 31 et al.
Requirements for Expanded Definition of Byproduct
Material; Proposed
071113BOD
MOTION:
090208BOD
MOTION: It was moved, seconded and voted that the SNM
Board of Directors ensure that the SNM Government
Relations Joint Task Force address and respond to the
Joint Commission’s adoption of the CMS’ Hospital
Conditions of Participation (COP’s) into the hospital
accreditation program. The SNM Government
Relations Committee shall report any/all progress back
to the SNMTS Leadership.
2010/0115BOD
MOTION It was moved, seconded and voted to approve the
Issue Brief of HR4371 as amended.
It was moved, seconded and voted to endorse the
government relations plan with the stipulation that
the leadership would discuss possible funding options
and make recommendations to the board for approval
on the December conference call.
69
HISTORICAL REFERENCE
960413BOD-05
960602HOD-08
NUCLEAR MEDICINE ARCHIVES; REVIEW AND APPROVAL OF SNM
ARCHIVES PROPOSAL AND RECOMMENDATIONS OF
THE COMMITTEE ON ARCHIVES
MOTION:
To approve the concept of a combined organizational
archive and history center, particularly with respect to
the bequests of papers of nuclear medicine pioneers.
MOTION:
To approve the initial consultation of SNM Staff with
Nancy Knight, Ph.D., former senior archivist, Center
for the American History of Radiology. Consultation
would comprise such topics as (a) criteria for archival
selection (b) logistics of acceptance of materials (c)
legal and financial ramifications and (d) site
assessment at a cost of approximately $4,000 for her
services for the remainder of the current fiscal year.
MOTION:
That the Board of Directors empowers the Committee
on Archives to seek funding of the SNM Archives
from the SNM Education and Research Foundation, as
well as the families of Dr. Marshall Brucer, Dr. John
Kuranz, etc.
NUCLEAR MEDICINE HISTORY CENTER
MOTION:
960531BOD-12
To endorse the concept to establish a Nuclear
Medicine History Center at the SNM Reston, VA
Headquarters Office. APPROVED.
NUCLEAR MEDICINE HISTORY CENTER
MOTION:
To endorse the concept to establish a Nuclear
Medicine History Center at the SNM Headquarters in
Reston, VA.
To endorse the concept to establish a Nuclear
Medicine History Center at the SNM Reston, VA
Headquarters Office. (Resolution, June 2, 1996,
House of Delegates) next review date 2001.
050918BOD
National Museum of Nuclear Science and History
MOTION:
It was moved, seconded and voted to form a
committee to investigate financial and academic
70
consulting support for the new National Museum of
Nuclear Science and History. The task force is to
report back to the Board by the Midwinter meeting.
050918BOD
International Museum of Surgical Science
MOTION:
060211BOD
It was moved, seconded and voted to refer approval
of the request of $5,000 for support for Phase 2 of
the International Museum of Surgical Science’s
exhibit on modern medical imaging to the task force
chaired by Dr. Zubal that is looking to SNM support
for museums.
MOTION: It was moved, seconded and voted, that the Society
will waive the fees that the National Museum of
Nuclear Science and History would normally pay for
occupying a booth in the Exhibitors Hall in San Diego.
MOTION: It was moved, seconded and voted that the Society
will donate a one page advertisement space in the
Journal of Nuclear Medicine where the National
Museum of Nuclear Science and History (NMNSH)
could make the public aware of its existence in
program offerings. The NMNSH would supply the
artwork and design layout. The ad would be run
every 3 months over the next 12 months.
MOTION:
MOTION:
It was moved, seconded and voted that the SNM’s PR
committee will send a written flyer to industry about
the National Museum of Nuclear Science and History’s
(NMNSH’s) appeal to manufacturers and other
organizations for naming rights, sponsorship, and
donation opportunities.
It was moved, seconded and voted that during the
opening remarks at the annual summer meeting in San
Diego, an announcement be made regarding the
establishment of the National Museum of Nuclear
Science and History, with content of the announcement
left to the discretion of the chair of the Scientific
Program Committee.
71
HOUSE OF DELEGATES
950408EC-10
COMMISSION PROCEDURES AND COUNCILS TRANSITION TO THE
HOUSE OF DELEGATES: NUMBER OF APPOINTED
DELEGATES
MOTION:
960602HOD-03
ELECTION OF HISTORIAN
MOTION:
960602HOD-01
960602
The Society does not make any additional efforts this
year to determine numbers of members for Primary
Councils.
The voting members of the House voted for the
Historian of the Society by a secret ballot distributed
at the June 2, 1996 meeting of the House. Dr.
Dennis D. Patton was elected as the Historian of the
Society.
ORGANIZATIONS WITH NON-VOTING REPRESENTATIVES TO THE
HOUSE OF DELEGATES
MOTION:
To invite the following organizations to designate a
representative to attend meetings of the House of
Delegates with the right to speak. APPROVED.
American College of Nuclear Medicine (ACNM)
American College of Nuclear Physicians (ACNP)
American College of Radiology (ACR)
Commission on Nuclear Medicine
American Society of Nuclear Cardiology (ASNC)
Institute for Clinical PET (ICP)
Society of Nuclear Medicine in Canada (SNMC)
MOTION:
Subcommissions of the House of Delegates to be
designated unofficially as Committees of the House of
Delegates. (Resolution, June 2, 1996, House of
Delegates) next review date 2001.
72
MOTION:
Members of the Committees of the House of
Delegates serve for a term of three (3) years, with a
maximum of two (2) full terms, with the terms
staggered, so that three (3) are appointed each year
with the understanding that the Chairman will come
from one of the nine (9) committee members.
Exceptions to the number of committee members are
noted in PROCEDURES. (Resolution, June 2, 1996,
House of Delegates) Next review date 2001.
980201
MOTION:
Be it resolved, that formal written reports of meetings
of the SNM Board of Directors and its Executive
Committee be distributed to the voting members
of the House of Delegates within thirty (30) days of
the regularly scheduled meetings of the House
of Delegates. (Resolution, February 1, 1998, House
Delegates) next review date 2003.
000603
MOTION:
It was moved, seconded and voted that the House 1)
reaffirm its policy of authorizing the Board of
Directors to negotiate and implement partnerships
with organizations with strategic interests compatible
with those of the Society, 2) that a House Task Force
be established to recommend policies
governing future partnerships, 3) that the House
approve a set of polices by the next Midwinter
Meeting and after consideration of the Task Force
recommendations and that no new Board approvals
of partnerships take place until the House acts on the
Task Force recommendations. (Resolution, June 3,
2000, House of Delegates) Next review date 2005.
010623
MOTION:
It was moved, seconded and voted that the President
appoint a task force of House members to review the
role and structure of the House to come back
to the HOD with a report and proposed bylaws
changes in an expeditious fashion. (Resolution,
June 23, 2001, House of Delegates) Next
review date 2006.
73
020614
MOTION:
It was moved, seconded and voted to approve the
Procedures document as amended. (Resolution, June
14, 2002, Board of Directors) Next review date 2007.
020615
MOTION:
It was moved, seconded and voted to approve the
Bylaws changes related to the new restructuring of
the SNM HOD. (Resolution, June 15, 2002, Board of
Directors) next review date 2007.
020615
MOTION:
It was moved, seconded and voted to approve the
recommendations from the Task Force on Policies and
Procedures. (Resolution, June 15, 2002, Board of
Directors) next review date 2007.
020615
MOTION:
It was moved, seconded and voted to approve the
revised SNM Procedures document. (Resolution, June
15, 2002, Board of Directors) Next review date 2007.
030126
MOTION:
It was moved seconded and voted to provide the
Centers of Excellence with two (2) votes on the SNM
House of Delegates. (Resolution, January 26, 2003,
Board of Directors) Next review date 2008.
090913BOD
MOTION
It was moved, seconded and voted to create a
Governance Task Force to develop a plan for
restructuring the Society and possibly eliminating the
HOD.
2010/0129BOD
MOTION
It was moved, seconded and voted to approve the
Governance Review Task Force recommendation as
outlined above (APPENDIX 40).
2010/0130BOD MOTION
It was moved, seconded and voted to form a new joint
task force to review the recommendations of the BOD
Task Force on potential restructuring the
responsibilities of the HOD, the SNM BOD will retract
its prior vote to send the BOD task force
recommendations to the bylaws committee pending
the new review by the joint BOD & HOD Task Force.
74
International
050615BOD
MOTION:
It was moved, seconded and voted to table the
proposed motion until the Board has adequate
information on its financial impact, including if
US residents are included in the motion. To
approve that the SNM offer free membership
to fellows and trainees of international nuclear
medicine programs, for a two-year trial period.
The membership will include access to an
electronic copy of the JNM and JNMT.
050615BOD
MOTION:
It was moved, seconded and voted that the
SNM provide support for international meetings
and programs. The SNM provide no more than
three speakers per meeting in response to
support for international programs and
meetings. This support will be based on a predetermined amount per individual speaker and
total budget. This support will normally be
given only for major organizations and not
regional programs and will be based on a firstcome, first-serve basis. The total budget
amount will be determined during the budget
development process, where the Finance
Committee will recommend a budget to the
Board.
050615BOD
MOTION:
It was moved, seconded and voted that the
SNM continue to provide support for in kind
assistance upon request to international
organizations putting together educational
programs and meetings. The SNM will share its
experience and expertise to international
organizations on a case-by-case basis and
within the limits of the resources that the
Society can provide.
050918BOD
MOTION:
It was moved, seconded and voted that
the SNM would support the following large
international meeting (This support would be
in the form of providing up to 3 speakers per
meeting (which includes representation by
Society leadership) unless additional resources
are available.)
75





European Association of Nuclear Medicine
Japanese Society of Nuclear Medicine
World Federation of Nuclear Medicine and Biology
Association of the Latin American Societies of Nuclear Medicine and Biology
Asia-Pacific Conference
070216BOD
MOTION:
070415BOD
MOTION:
070929BOD
MOTION:
The motion was moved, seconded and voted to
approve SNM giving a contribution of $5,000 to
IAEA to support meeting expenses including
speaker travel reimbursement.
It was moved, seconded and voted to send a
letter to IAEA stating SNM’s disapproval of the
new Radiation Safety sign, designed and
accepted by IAEA, as it will be counter
productive to the principle for which the IAEA
was formed and that is " to promote peaceful
applications of atomic energy for the benefit of
mankind. SNM believes that, if used
inappropriately, the sign will discourage
patients and public alike to undergo diagnostic
and therapeutic procedures that are based on
the use of radioactivity or external radiation.
It was moved, seconded and approved to
continue the discussion between the SNM
Leadership, Dr. Heinrich Schelbert and the
CSNM to develop a proposed business plan.
76
LIAISON / RELATED ORGANIZATIONS
950212BOT-18
PROPOSED ACADEMY OF RADIOLOGY RESEARCH (ARR)
MOTION:
960413BOD-03
SNM MEMBERSHIP IN THE ACADEMY OF RADIOLOGY RESEARCH
(ARR)
MOTION:
951021BOD-07
The Society will join the ARR as a participating
member, pending identification of funding for its
membership dues.
ACADEMY OF RADIOLOGY RESEARCH (ARR)
MOTION:
950609BOD-13
To resubmit a request to the SNM Education &
Research Foundation for funding that portion
($5,800) of the full membership fee for the Society as
a participating member ($18,000), which is allowed
for
501 (c) (3) organizations, given the 43% of current
year ARR funds associated with lobbying.
ACADEMY OF RADIOLOGY RESEARCH (ARR) PARTICIPATING
MEMBERSHIP
MOTION:
950210EC-05
To approve, in principal, SNM efforts to participate in
Academy of Radiology Research. Dues to be
negotiated and forwarded at a later date.
To refer issue to the Board of Trustees for its review
and discussion. The Executive Committee will explore
participation and cost for same, with the assistance of
Dr. Alazraki.
PROPOSED ACADEMY OF RADIOLOGY RESEARCH (ARR) STATUS
REPORT
MOTION: To forward a recommendation to the Committee on
Finance that the Society contribute $2,500 for Society
Membership in the ARR for review and
recommendation at its Saturday, June 10, 1995
meeting. The members noted that they preferred
that this membership be a collaborative membership
including the ACNP, ACNM, ASNC, ABNM, ICP, etc. [3
Opposed]
77
950610BOD-05
SUPPORT FOR AHCPR FUNDING
MOTION:
951021BOD-02
ACR APPROPRIATENESS CRITERIA FOR NUCLEAR MEDICINE
STUDIES
MOTION:
960413BOD-11
The Committee on Health Care Reform [Commission
on Health Care Policy] recommends that the Board of
Directors charge the Government Relations Office to
lobby for the continuation of the AHCPR activities..
The Board of Directors approves the Society Task
Force on ACR Appropriateness Criteria to be housed
within the CHCP.
COMMUNICATION FROM THE AMERICAN NUCLEAR SOCIETY (ANS)
REGARDING THE NAMING OF ELEMENTS,
ESPECIALLY IN RELATIONSHIP TO THE ELEMENT
DISCOVERED BY DR. GLENN SEABORG
MOTION: To forward a letter directly to the IUPAC stating that
the Society of Nuclear Medicine (SNM) supports
elemental naming to include living individuals.
960114HOD-06
CERTIFICATION COUNCIL IN NUCLEAR CARDIOLOGY
MOTION:
Whereas the Society of Nuclear Medicine (SNM)
recognizes the importance of ensuring quality in the
limited practice of nuclear medicine and supports
efforts to find a mechanism to ensure quality in the
practice of cardiovascular nuclear medicine, BE IT
RESOLVED that the Society communicate to the ASNC
that it cannot respond by sending a member to
participate in a certifying exam as described to the
Society, but suggest as an alternative that the ASNC,
the SNM, the ACNP, the ACNM, the ABR, the ABNM,
the ABIM and the Residency Review Committee for
Nuclear Medicine develop conjointly a mechanism to
achieve quality certification in cardiovascular nuclear
medicine.
MOTION:
To name a representative from the Society of Nuclear
Medicine (SNM) to the ASNC to communicate with
them about this alternative recommendation and to
be able to communicate back to the Society what
they are doing in their discussion.
78
960112BOD-11
CERTIFICATION COUNCIL IN NUCLEAR CARDIOLOGY
MOTION:
951021BOD-05
MEDICAL SPECIALTY COALITION
MOTION:
951021BOD-08
To join the Syncor International Corp. v. Shalala
lawsuit as an intervener at no cost to the Society,
pending expeditious SNM legal counsel review of any
risk to the Society.
WORLD FEDERATION OF NUCLEAR MEDICINE & BIOLOGY
(WFNMB) SNM DUES PAYMENTS
MOTION:
960114HOD-O1
Allocate $8,500 in the budget for Sheldon Trubatch to
continue pursing the NRC, with a note that by passing
this motion, the Board would be adding $8,500 to the
budget deficit. The motion passed 6-5.
SOCIETY "INTERVENTION" IN SYNCOR INTERNATIONAL CORP v.
SHALALA
MOTION:
950210EC-04
To increase the SNM level of support for the NCRP
from $500.00 to $1,500.00 per annum, with
recommendation for further SNM participation on
NCRP Committees.
SHELDON TRUBACH RETAINER FOR LOBBYING EFFORTS
TOWARDS THE NRC
MOTION:
951021BOD-10
To approve Society membership to the Medical
Specialty Coalition, with a $3,000 annual budget,
including membership fee as well as associated travel
expenses for SNM Representative(s).
REQUEST TO INCREASE SNM FUNDING FOR NCRP
MOTION:
950408EC-NB1
To table further discussion on this topic.
To approve funding for Annual SNM Dues on the
WFNMB for U.S. Physician Full Members at $1.00
each year through the 1998 WFMNB Congress.
INTERSOCIETY/INDUSTRY COMMITTEE
79
MOTION:
960112BOD-01
To accept the report of the Intersociety/Industry
Committee, as presented and to endorse the mission
statement and the four assumptions and report that
underlie the whole process.
INTERSOCIETY/INDUSTRY COMMITTEE
MOTION:
To approve the January 5, 1996 Intersociety/Industry
Committee Progress Report, as submitted.
960114
MOTION:
Whereas the Society of Nuclear Medicine (SNM)
recognizes the importance of ensuring quality in the
limited practice of nuclear medicine and supports
efforts to find a mechanism to ensure quality in the
practice of cardiovascular nuclear medicine, BE IT
RESOLVED that the Society communicate to the
ASNC that it cannot respond by sending a member to
participate in a certifying exam as described to the
Society, but suggest as an alternative that the ASNC,
the SNM, the ACNP, the ACNM, the ABR, the ABNM,
the ABIM and the Residency Review Committee for
Nuclear Medicine develop conjointly a mechanism to
achieve quality certification in cardiovascular
nuclear medicine. (Resolution, January 14, 1996,
House of Delegates) Next review date 2001.
960602
MOTION:
To name a representative from the Society of Nuclear
Medicine (SNM) to the ASNC to communicate with
them about this alternative recommendation and
to be able to communicate back to the Society what
they are doing in their discussion. (Resolution, June
2, 1996, House of Delegates) Next review date 2001.
960602
MOTION:
To invite the following organizations to designate a
representative to attend meetings of the House of
Delegates with the right to speak:
American College of Nuclear Medicine (ACNM)
American College of Nuclear Physicians (ACNP)
American College of Radiology (ACR)
Commission on Nuclear Medicine
American Society of Nuclear Cardiology (ASNC)
Institute for Clinical PET (ICP)
Society of Nuclear Medicine in Canada (SNMC)
80
(Resolution, June 2, 1996, House of Delegates)
Next review date 2001.
970601
MOTION:
To endorse the Health Physics Society Position
Statement, “Radiation Risk in Perspective”, March,
1996. STATEMENT OF THE ISSUE: Radiation
absorbed does under 5 rem / y or a lifetime does of
10 rem over background is not associated with
measurable risk. (Resolution, June 1, 1997, House of
Delegates) next review date 2002.
980201
MOTION:
Be it resolved that the SNM President appoint a
special Task Force to prepare a timely response to the
1/30/98 Nuclear Regulatory Commission (NRC) draft
rewrite of 10 CFR Part 35. This Task Force report will
be transmitted through the Government Relations
Committee to the NRC and subsequently provided to
the House of Delegates. Submitted By : Michael D.
Devous, Sr., Ph.D. (Resolution, February 1, 1998,
House of Delegates) Next review date 2003.
980607
MOTION:
It was moved, seconded and voted that the SNM will
send a liaison individual to the Certification Council of
Nuclear Cardiology. (Resolution, June 7, 1998,
House of Delegates) Next review date 2003.
000603
MOTION:
It was moved, seconded, but not voted that the
partnership agreement with General Electric Medical
Systems be rescinded. (Resolution, June 3, 2000,
House of Delegates) Next review date 2005.
General Electric Medical Systems be rescinded.
(Resolution, June 3, 2000, House of Delegates) Next
review date 2005.
010211
MOTION:
It was moved, seconded and voted that the Guideline
son External Partnerships are adopted as presented.
(Resolution, February 11, 2001, House of Delegates)
Next review date 2006.
030125
MOTION:
It was moved, seconded and voted to endorse
pursuit of concept for 2004 Basic Science meeting,
and to include this concept into the FY2003-2004
annual budget. (Resolution, January 25, 2003, Board
of Directors) Next review date 2008.
81
060910BOD
ICANL ACCREDITATION COMMISSION
MOTION:
It was moved, seconded and voted to provide a
$25,000 loan to the organization for start up costs.
070216BOD
AMERICAN BOARD OF RADIOLOCY
MOTION:
The motion was moved, seconded and voted to
approve the American Board of Radiology Proposal
for Accessing CME Data from CME Gateway for the
purpose of assisting ABR diplomates in completing
Maintenance of Certification requirements.
070415BOD
070713BOD
MACNIS
MOTION:
IMT
MOTION:
It was moved, seconded and voted to approve that
Peter S. Conti, MD be the SNM Liaison to the
Executive Council of MACNIS.
It was moved, seconded and voted to support the
proposal to have SNM pursue the IMT merger.
AMI/SNM Meeting in Niece, France
MOTION:
It was moved, seconded and voted to endorse the
collaboration with AMI/SMI on the Nice, France
meeting.
070827BOD
NUCLEAR MEDICINE TOMORROW
MOTION:
It was moved, seconded and voted to endorse the
Nuclear Medicine Tomorrow Meeting.
070929BOD
IMT
MOTION:
It was moved, second and voted to approve the SNM
leadership to enter into discussions with IMT
regarding the proposal and possible relationship with
the IMT and report back to the board by the first
fortnight in November.
AMERICAN MEDICAL ASSOCIATION
MOTION:
It was moved, seconded and voted to approve the
five-year review process for representation in the
American Medical Association House of Delegates.
071113BOD
AMERICAN SOCIETY NUCLEAR CARIOLOGY
MOTION:
It was moved, seconded and voted to endorse the
ASNC “Clinical Imaging Prevention: Directed Strategies
for Improved Detection of Pre-Symptomatic Patients
82
with Undetected Atherosclerosis,” and request that an
SNM Cardiovascular Council be represented on the
Part 2 committee.
080117BOD
WORLD MOLECULAR IMAGING CONFERENCE
MOTION:
It was moved, second and voted unanimously to
approve SNM’s participation in the WMIC as outlined
above.
080730BOD
080614BOD
090913BOD
MOTION:
It was moved, seconded and voted to request that
ABNM begin dialogue with the ABR regarding Nuclear
Medicine Training Programs.
MOTION:
It was moved, seconded and voted to have SNM
named as a sponsor, including an SNM representative
and monetary support up to $100,000.
MOTION:
It was moved, seconded and voted for the SNM to
support and become a part of the Alliance for
Radiation Safety in Pediatric Imaging.
Advisory Committee on the Medical Use of Isotopes (ACMUI).
MOTION:
It was moved, seconded and voted to nominate
Henry Royal, MD as SNM’s nominee to the Advisory
Committee on the Medical Use of Isotopes (ACMUI).
2010/0603BOD
MOTION
It was moved, seconded and voted that organizations
managed by SNM should be charged full expenses for
management. This policy should go into effect at the
end of the existing contracts.
2011/0114BOD
MOTION
It was moved, seconded and voted unanimously to
approve and endorse SNM collaboration with the
Geneva Imaging Symposium.
2011/0121BOD
MOTION
It was moved, seconded and voted (2 abstentions) to
approve and endorse the Radiotherapeutic
Foundation Project. (APPENDIX 41)
2011/0917BOD
MOTION
It was moved, seconded and voted to make donation
to Image Gently campaign in the amount of $2,500 to
support the printing and postage for the posters.
Accreditation Council for Graduation Medical Education (ACGME)
2011/1121BOD MOTION It was moved, seconded and voted to approve the
83
attached letter from the SNM to the ACGME
regarding Therapies Involving Oral Administration of
I-131 (APPENDIX 69).
2011/0121BOD
MOTION
It was moved, seconded and voted to approve the
SNM comments to ACGME re: Common Program
Requirements (APPENDIX 70).
Center for Medicare and Medicaid Service (CMS)
2012/0117BOD
MOTION
It was moved, seconded and unanimously voted to
approve the CMS Coverage with Evidence
Development letter as submitted. (APPENDIX 71)
84
MEMBERSHIP COMMITTEE
960531BOD-14
ANNUAL DUES BILLING PROCESS
MOTION:
To implement an anniversary billing system for new
members only, assigning staff the responsibility of
evaluating and subsequent reporting on the financial
impact and logistics of converting existing SNM
Members to an anniversary billing system.
010210
MOTION:
It was moved, seconded and voted to accept the
proposal to create an SNM membership
category for corporate membership and that staff
create a detailed corporate membership proposal for
consideration at the June meeting.
030620
MOTION:
It was moved, seconded and voted to approve
grandfathering all current Technologist Voting
Members into the Associate Member category and
close the Technologist Voting category to new
applicants. (Resolution, June 20, 2003, Board of
Directors) Next review date 2008.
030620
MOTION
It was moved, seconded, and voted that the SNM
Board approved the new membership benefit / Wells
Fargo – The Capital for Knowledge Program.
(Resolution, June 20, 2003, Board of Directors) Next
review date 2008.
090612BOD
MOTION
It was moved, seconded and voted that Nuclear
Medicine and Radiology residents have a free
membership to the SNM, throughout their residency.
This membership would be for the electronic journals
rather than hard copy.
It was moved, seconded and approved that Nuclear
Medicine Residents from Australia and New Zealand
have free SNM Membership during their residency as
approved by their residency director.
090827BOD
MOTION
It was moved, seconded and voted to increase full
member dues by $80.00 and emeritus dues by
$10.00.
85
090913BOD
MOTION
It was moved, seconded and voted to institute a oneyear special membership promotion of 50% discount
off first-year membership dues for full and associate
member categories and a 50% discount on the
member registration fee during SNM meetings for
one-year for new SNM members (never before
members) who are members of “related
organizations”.“Related organizations” would include
AACR, AAPM, AMI, EANM, ESMI, FASMI, ICUS, IEEE,
ISMRM, RSNA, SMI, and SPIE.
It was moved, seconded and voted to offer scientists
in- training free membership. SNM will require proof
of full-time student status from a mentor or program
director from their institution. Trainees will get free
membership, for up to three years, with proof of post
doctorial training from an advisor.
2010/0129BOD MOTION
It was moved, seconded and voted to change the
associate categories to read “masters or
baccalaureate degree.”
It was moved, seconded and voted to incorporate
levels of membership for a Scientific Laboratory
Professional into the membership categories as
outlined in the SNM Bylaws. Expand language in Full
Member, Associate Members, Technologist, Affiliate
and In-Training categories to be inclusive of all types
of molecular imaging and therapy.
It was moved, seconded and voted to institute a
two-year special membership dues promotion of
50% off the technologist membership dues (current
promotion would be $52.00) per year for Scientific
Laboratory Professional (Technologist SectionSNMTS). This promotion will be reviewed in two
years from its start date to determine if it should
continue.
2010/0709BOD MOTION
It was moved, seconded and voted that the dues for
international Full members be increased by $25.00
and mailing the journal to international members be
reinstated.
86
2012/0608BOD MOTION
It was moved, seconded and voted to approve the
transition rate for scientists in- training.
87
MEETINGS
941008EC-14
1995 SNM LEADERSHIP MEETING
MOTON:
950610BOD-04
1995 LEADERSHIP CONFERENCE
MOTION:
960531BOD-05
The Executive Committee [Board of Directors]
recommended that an action plan be derived by the
Focus Group on Practice Issues and the Focus Group
on Research and the Development.
REVIEW OF THE SNM CALENDAR AND PROTOCOL FOR
DETERMINING FUTURE MEETING SITES AND DATES
OF THE SNM BOARD OF DIRECTORS MEETINGS.
MOTION:
960413BOD-09
To endorse the program as a matter of high priority
within the Society along with a budget up to $25,000.
To schedule the Spring, 1997 meeting of the Board of
Directors for Saturday and Sunday, April 5-6, 1997.
REVIEW OF THE SNM CALENDAR AND PROTOCOL FOR
DETERMINING FUTURE MEETING SITES AND DATES
OF SNM BOARD OF DIRECTORS MEETINGS.
MOTION:
The Society of Nuclear Medicine (SNM) will schedule
the dates and sites one year in advance of the
subsequent Fall and Spring Meetings of the Board of
Directors at the end of each of these meetings.
960413BOD-GPC ANNUAL MEETING SAP
MOTION:
Request for endorsement of Standard Administrative
Procedures (SAP) dealing with affiliated group
meetings at the Annual Meeting.
960112BOD-NBC PROPOSAL FOR A PERSONALIZED MEETING SCHEDULE FOR
PARTICIPANTS AT THE SNM ANNUAL MEETING TO
BE SPONSORED BY MALLINCKRODT
MOTION:
To approve this proposal which will be managed by
the Department: Meeting Services on behalf of the
Committee on Technical Exhibits, while addressing
concerns of the Committee regarding management of
88
this activity on the floor of the Technical Exhibits at
the Annual Meeting.
960112BOD-GPC FUTURE SITES FOR SNM MID-WINTER MEETING
MOTION:
951021BOD-18
SNM ANNUAL MEETING HANDOUTS
MOTION:
951021BOD-14
Be it resolved that the Board of
Directors support the production of
Syllabi for categorical and CME courses
at the 1996 SNM Annual Meeting,
providing the cost can be covered by
adjusting registration for such courses
or sales of syllabi. Be it further resolved
that alternative methods of publication
be considered in future years.
ANNUAL MEETING NEEDS ASSESSMENT
MOTION:
951021BOD-15
The future sites for the SNM Mid-Winter Meeting will
be located in the Southern sections of the United
States.
To approve a request from the
General Program Chairman and the
Scientific Program Chairman to
conduct an SNM Annual Meeting
Needs Assessment as identified
above.
FUTURE ANNUAL MEETING SITES AND MID-WINTER MEETING
SITES
MOTION:
To move the site of the 1998 SNM Annual Meeting
from New Orleans, LA to Toronto, Ontario, CANADA.
MOTION:
The Board of Directors directs the Department:
Meeting Services to configure a conjoint meeting of
the ACNP and the SNM in 1999 for Project
Integration.
950609BOD-NB2 FUTURE ANNUAL MEETING SITES
89
MOTION:
951021BOD-16
To approve the future Annual Meeting sites
recommended by the General Program Committee
which include: 1) 2001-Chicago, IL, 2) 2002-Los
Angeles, CA, and 3) Toronto, Canada.
AUDIENCE RESPONSE SYSTEM (READ WITH THE EXPERTS CE
COURSES)
MOTION:
To review and to approve request for $10,000
$13,000 for interactive audience response system for
four (4) continuing education courses at the 1996
SNM Annual Meeting.
050617BOD
MOTION: It was moved, seconded and voted to approve the
Annual Meeting Reimbursement Policy, attached as
Appendix 8.
050617BOD
MOTION: It was moved, seconded and voted to approve the
Mid-Winter Reimbursement Policy as originally
presented: Registration - Complimentary registration is
provided for all speakers and moderators. Travel
Reimbursement - All speakers receive travel
reimbursement (Coach airfare with cap at $450, one
night hotel and two-day per diem with cap at
$75/day).
080614BOD
MOTION It was moved, seconded and voted to approve the
proposed SNM/MICoE CV Imaging Symposium at NIH.
090612BOD
MOTION It was moved, seconded and voted that the following
travel reimbursement for non-member speakers
presenting at the SNM Annual Meetings be approved;
US or Canadian non-member speakers –
reimbursement for one night’s hotel stay, $450 cap
applied to other travel or lodging expenses, and
complimentary registration for meeting. International
non-member speakers – reimbursement for two night’s
hotel stay; $750 cap for other travel or lodging
expenses, and one-day complimentary registration to
meeting (day of presentation).
2010/0130BOD
MOTION It was moved, seconded and voted that the SNMTS
Executive Board approve the narrowing down of the
sites, from four to two, for the Annual Meeting, and
90
make a recommendation, on behalf of the SNMTS to
the SNM Board of Directors. Be it further resolved that
the remaining two sites be presented to the Executive
Board for recommendation, on behalf of the SNMTS,
to the SNM Board of Directors.
It was moved, seconded and voted to expand the site
selection committee to include an SNMTS
Representative (as determined by the SNMTS
Leadership) for both the annual and mid-winter
meeting.
2010/0813BOD
MOTION It was moved, seconded and voted that the revised
Reimbursement Policy for CE Speakers at the SNM
MWM Educational Symposia and ACNM annual
meetings be approved. This will provide
reimbursement for travel up to $500 and
complimentary registration.
It was moved, seconded and voted to change to the
reimbursement policy in order to reduce the speaker
travel line item by 15% (~$5,000). (1) All Categorical
speakers, regardless of member status, will receive
complimentary registration to the Categoricals on
Saturday at the Annual Meeting. (2) All non-member
speakers (US and Canada) for both Categoricals and
CE sessions will receive complementary full registration
to the Annual Meeting and will be reimbursed for
airfare up to $450, plus one night hotel in an amount
approximately equal to the mean hotel price (including
taxes). (3) All international non-member speakers for
both Categoricals and CE sessions will receive full
registration to the Annual Meeting and will be
reimbursed for airfare up to $750, plus two nights
hotel in an amount approximately equal to the mean
hotel price (including taxes).
2012/0608BOD
MOTION It was moved and voted to approve that SNM will have
a reimbursement policy for non-member speakers at the Mid-Winter Meeting (see
attached). SNM will offer reimbursement for up to 4 non-member speakers. However,
only 1 non-member speaker will be reimbursed for each half-day or evening session. To
be eligible for non-member speaker reimbursement, a Council/Center must demonstrate
that the proposed content area cannot be covered by a member speaker.
91
If the Council/Center requests a keynote speaker as part of the session, these speakers
can be funded through the Council/Center budget and be reimbursed for their direct
expenses including airfare, hotel, and ground transportation, up to a limit of $2,000 per
speaker.
Non-member speakers for the SNM Mid-Winter Educational Symposium will be
reimbursed as follows: Complimentary meeting registration to all meetings at MWM;
Airfare with $450 cap that can be applied to other travel or lodging expenses; Hotel
reimbursement for one night's hotel stay in an amount approximately equal to the
mean hotel price (including taxes, no incidentals). A speaker will be reimbursed for an
additional night's hotel stay if traveling from the opposite US coast. Per diem with $75
cap to be used for meals, ground transportation or other expenses. A speaker will be
provided with a second day of per diem if traveling from the opposite US coast.
2012/0608BOD
MOTION
It was moved, seconded and voted to approve a
discounted fee of $20.00 for council/center
members for physician’s categoricals.
92
Molecular Imaging Center of Excellence (MICE)
050918BOD
MOTION:
It was moved, seconded and voted to approve
the SNM Capital Campaign, Molecular Imaging:
Bench to Bedside”
060910BOD
MOTION:
It was moved, seconded and voted to approve
the Molecular Imaging Center Campaign
Strategic Plan recommendations, first year
deliverables, and budget. (APPENDIX 42).
070415BOD
MOTION:
It was moved, seconded and voted to approve
the Molecular Imaging Definition as stated
below:
Molecular imaging is the visualization, characterization, and measurement of biological
processes at the molecular and cellular levels in humans and other living systems.
o Molecular imaging typically includes two- or three- dimensional imaging as well
as quantification over time.
o The techniques used include radiotracer imaging/nuclear medicine, MRI,
MRS,optical imaging, ultrasound and others.
070601BOD
070929BOD
MOTION:
It was moved, seconded and voted that
interested practitioners may join the Molecular
Imaging Center of Excellence—and SNM—for a
free 90-day trial membership. After 90 days,
individuals will have to join the SNM as a
member to continue membership in the Center.
The trial membership may not be renewed.
MOTION:
It was moved, seconded and voted that invited
members and special invitees may receive a
one-year complementary membership in the
Molecular Imaging Center of Excellence—and
SNM. After one year, individuals will have to join
the SNM as a member to continue membership
in the Center. The complementary membership
may not be extended.
MOTION:
It was moved, seconded and approved that the
SNM BOD approves the proposed curriculum
(attached as Appendix 9) and for SNM to
formally submit a request to the Residency
Review Committee (RRC) and American Board
93
of Nuclear Medicine (ABNM) to consider
suggested revisions to the Nuclear Medicine
Residency Curriculum to incorporate more
molecular imaging topics.
2010/0813BOD
MOITON
It was moved, seconded and voted that the
SNM Board of Directors endorse the Scientist’s
Curriculum White Paper – with the suggested
changes (APPENDIX 43)
94
PHANTOM QUALITY ASSURANCE COMMITTEE
95
PET CENTER OF EXCELLENCE
960112BOD-16
ICP REQUEST FOR SNM TO JOIN MANAGED CARE TASK FORCE ON
CLINICAL POSITRON IMAGING
MOTION:
960531BOD-07
While the Society is not in a position to contribute
financially to this undertaking, it is willing to
participate in the deliberations with the expertise of
Society Members and that of the membership of the
Committee on PET.
PROPOSED SNM LEARNING CENTER
MOTION:
To endorse the concept of a nuclear medicine
learning center and encourage Dr. H. William Strauss
to develop a business plan for future review by the
Board of Directors.
PET Center of Excellence
Peter Conti, M.D., Chair of the Task Force on the PET Center of Excellence,
discussed the proposed structure and bylaws changes for this new organizational
category within SNM.
030125
MOTION:
It was moved, seconded and voted to accept
presented changes to the Bylaws creating Centers as
a new organizational category in the Society of
Nuclear Medicine, Inc. (Resolution, January 25, 2003,
Board of Directors) Next review date 2008.
030405
MOTION:
It was moved, seconded and voted to endorse thE
PET Myocardial Perfusion and Glucose Metabolism
Imaging Guideline. (Resolution, April 4-5, 2003, Board
of Directors) Next review date 2008.
030620
MOTION:
It was moved, seconded and voted to adopt the
revised SNM Procedure Guidelines for the Diagnosis of
Renovascular Hypertension v2.3. (Resolution, June
20, 2003, Board of Directors) Next review date 2008.
96
030620
MOTION:
It was moved, seconded and voted to adopt the
revised SNM Procedure Guideline for Renal Cortical
Scintigraphy in Children V2.3. (Resolution, June 20,
2003, Board of Directors) Next review date 2008.
030620
MOTION:
It was moved, seconded and voted to adopt the
revised SNM Procedures for Hepatic and Splenic
Imaging V2.3. (Resolution, June 20, 2003, Board of
Directors) Next review date 2008.
030620
MOTION:
It was moved, seconded and voted to adopt the SNM
Procedures for Bone Scintigraphy V2.3. (Resolution,
June 20, 2003, Board of Directors) Next review date
2008.
030620
MOTION:
It was moved, seconded and voted that the
Guidelines Committee will review Item C Page 3 and
replace with a more general statement. (Resolution,
June 20, 2003, Board of Directors) Next review date
2008.
080612BOD
MOTION
It was moved, seconded and voted to approve the
Referring Physicians Plan as outlined and to continue
conversations around the Referring Physicians Plan
with industry representatives. (APPENDIX 64)
2012/0128BOD
MOTION
It was moved and unanimously voted that the PET
Center of Excellence be permitted to carry over
funds from year to year up to $20,000.
97
Political Action Committee
030620
MOTION:
It was moved, seconded and voted that the SNM
political action committee be disbanded and any
balances in its account be distributed in accordance
with the bylaws and rules of the PAC and in
accordance with federal law and regulations.
98
PRACTICE GUIDELINES COMMITTEE
Proposed Nuclear Medicine Procedure Guidelines:
1.
2.
3.
4.
5.
6.
7.
8.
Pediatric Sedation in Nuclear Medicine
Radionuclide Cystographer in Children
Diuretic Renography in Children
Renal Cortical Scintigraphy in Children
Brain Perfusion Single Photon Computer Tomography (SPECT)
Hepatic and Splenic Imaging
C-14 Urea Breath Test
Tumor Imaging using F-18 FDG
At its June 1, 1996 Meeting, the Board of Directors approved the procedure guidelines,
including revisions made at the Procedure Guideline Reference Committee meeting on
June 1, 1996. The Board of Directors unanimously approved the guidelines be
forwarded to the House of Delegates for final approval.
960602
MOTION:
To approve the new Nuclear Medicine procedure
guidelines (Resolution, June 2, 1996, House of
Delegates) Next review date 2001.
970601
MOTION:
To change the designation of the PD-1 guideline
(urinary tract infections in children) to “no action”.
(Resolution, June 1, 1997, House of Delegates) Next
review date 2002.
970601
MOTION:
To ratify the recommendations of the SNM Task Force
on External Guidelines as amended. (Resolution, June
1, 1997, House of Delegates) Next review date 2002.
980607
MOTION:
It was moved, seconded and voted that the four
Procedure Guidelines listed below be approved:



Procedure Guideline for Hepatobiliary Scintigraphy
Procedure Guideline for C-14 Urea Breath Test
Procedure Guideline for Use of
Radiopharmaceuticals
 Procedure Guideline for Gallium Scintigraphy in the
Evaluation of Malignant Disease
(Resolution, June 7, 1998, House of Delegates) Next
review date 2003.
99
010211
MOTION:
It was moved, seconded and voted that the
Somatostatin Receptor Scintigraphy Procedure
Guideline be approved. (Resolution, February 11,
2001, House of Delegates) Next review date 2006.
050918BOD
MOTION:
It was moved, seconded and voted to approve the
Procedure Guideline for Therapy of Thyroid Disease
with Iodine-131 (Sodium Iodine)
060211BOD
MOTION:
It was moved, seconded and voted to approve the
edited language within the Myocardial Perfusion
Imaging Guideline as it pertains to qualifications and
MOC issues. The Committee recommends that the
BOD approve the language as well. At the same time,
the Committee recognizes that the guideline is outdated and in need of revision. (APPENDIX 10)
MOTION:
It was moved, seconded and voted, that the BOD
approve the Procedure Guideline for Tumor Imaging
Using FDG-PET/CT version 0.7 (APPENDIX 65)
MOTION:
The Committee recommends that the BOD approach
ASNC to discuss their newly developed comprehensive
Nuclear Cardiology Guideline and decide whether
collaboration with the SNM Guidelines Committee is
appropriate.
060424BOD
MOTION:
The Committee recommends that the BOD approve
the Procedure Guideline for SPECT/CT Imaging
version 0.6
060602BOD
MOTION:
The Committee recommends that the BOD approve
the “Statement on Credentialing and Delineation of
Privileges for CT Performed in Conjunction with PET or
SPECT.” If approved, the Committee recommends
that the statement be published in the Journal of
Nuclear Medicine. (APPENDIX 11)
MOTION: The Committee recommends that the BOD approve the
revised “Qualifications of Personnel” statement. Once
approved, this statement will be inserted into the
Guideline on General Imaging and serve as a reference
in all SNM guidelines moving forward.
100
In each guideline, please insert:
V. Qualifications of Personnel
Please refer to the Guideline on General Imaging. No qualifications unique to
this procedure are applicable.
In General Imaging Guideline please insert:
VII. Qualifications of Personnel
A. The qualifications and responsibilities of physicians supervising and interpreting
Nuclear Medicine studies should include:
- current board certification (ABNM or equivalent as defined in the SNM
Statement of Credentialing and Delineation of Privileges)
- participation in MOC (maintenance of certification)
B. The qualifications and responsibilities of technologists performing Nuclear Medicine
procedures should be consistent with the SNMTS Scope of Practice for NMT.
060910BOD
060910BOD
MOTION: The Committee recommends that the BOD approve the
“Statement on Credentialing and Delineation of
Privileges for Cardiovascular CT.” If approved, the
Committee recommends that the statement be
published in the Journal of Nuclear Medicine.
(APPENDIX 12)
MOTION:
The Committee recommends that the BOD approve
the “Statement on Credentialing and Delineation of
Privileges for PET.” If approved, the Committee
recommends that the statement be published in the
Journal of Nuclear Medicine. (APPENDIX 13)
MOTION:
It was moved, seconded and voted to approve the
Procedure Guideline for Thyroid Scintigraphy v2.4
MOTION:
It was moved, seconded and voted to approve the
Procedure Guideline for Thyroid Uptake Measurement
v2.
MOTION:
It was moved, seconded and voted to approve the
Procedure Guideline for Scintigraphy for Differentiated
Papillary and Follicular Thyroid Cancer v2.6
101
070217BOD
MOTION:
MOTION:
070415BOD
070601BOD
MOTION:
It was moved, second and voted that the SNM
participate with the AMA Physician Consortium
Group to serve as a lead organization on
performance measures for myocardial perfusion
imaging and FDG PET/CT for Oncology.
Be it resolved, that a Subcommittee of the Practice
Standards Committee be created to evaluate and
recommend credentialing in various nuclear medicine
procedures.
It was moved, seconded and voted to approve the
elimination of Section III, “Examples of Clinical
Research Applications”, from all SNM procedure
guidelines.
MOTION:
It was moved, seconded and voted to approve the
Procedure Guideline for Diuretic Renography in
Children v2.8
MOTION:
It was moved, seconded and voted to approve the
manuscript “Consensus Recommendations for Gastric
Emptying Scintigraphy,” jointly developed by the SNM
and the American Neurogastroenterology and Motility
Society. The Committee further recommends that the
consensus document be published in an upcoming
issue of JNM. (Appendix 14)
MOTION:
It was moved, seconded and voted that the SNM BOD
begin work on developing practice standards for the
following three areas:
Gastric Emptying Scintigraphy (conjointly with the GI Council and the American Motility
Society)
Hybrid Cardiac Imaging (conjointly with the ACR, ASNC and ACC)
Radioimmunotherapy for lymphoma (conjointly with ASTRO, ASCO and ASH)
070713BOD
MOTION:
It was moved, seconded and voted to approved the
recommendations from the joint SNM/ASCO PET/CT
Panel entitled, “Recommendations of the use of FDG
(fluorine-18), PET in Oncology”.
102
2011/0918 BOD MOTION
It was moved, seconded and voted to approve the
SNM Practice Guideline for Parathyroid Scintigraphy
V4.0. (APPENDIX 66)
2011/1026 BOD MOTION
It was moved and unanimously voted to approve
the SNM Practice Guideline for Dopamine
Transporter Imaging with 123I-Ioflupane SPECT
V1.0. (APPENDIX 67)
2012/0608BOD MOTION
It was moved, seconded and voted to refer the
EANM Guideline for MIBG Therapy back to the
Procedure Guidelines Committee to discuss and
include language addressing the issue of nonapproved applications in the United States.
2012/0608BOD MOTION
It was moved, seconded and voted to approve the
SNM Guideline for Brain Death Scintigraphy V2.0.
(APPENDIX 76)
2012/0608BOD MOTION
It was moved, seconded and voted to approve the
SNM It was moved, seconded and voted to approve
the SNM Guideline for Therapies of Thyroid
Disease. (APPENDIX 77)
.
2012/0608BOD MOTION
It was moved, seconded and voted to approve the
SNM It was moved, seconded and voted to approve
the SNM-EANM Guideline for Guideline
Development. (APPENDIX 78)
103
Procedure Guidelines Committee
020612
MOTION:
It was moved, seconded and voted that the BOD
approves the Procedure for SNM Review of
External Procedure and Practice Guidelines.
080614BOD
MOTION:
It was moved, seconded and voted to approve
the Myocardial Perfusion Imaging Procedure
Guideline.
090206
MOTION:
It was moved, seconded and voted to approve
the revised
Procedure Guideline for Adult Solid
Meal Gastric Emptying Study, version (2.0).
It was moved, seconded and voted to approve
the Procedure Guideline for Brain Perfusion Single
Photon Computed Tomography (SPECT) Using
Tc-99m Radiopharmaceuticals.
090126BOD
MOTION
It was moved, seconded and voted to approve and
endorse the “Appropriate Use Criteria for Cardiac
Raionuclide Imaging.”
090612BOD
MOTION
It was moved, seconded and voted that the SNM
Board of Directors approved and endorse the ASNC
PET Myocardial Perfusion and Metabolism Clinical
Imaging Guideline.
2010/0130BOD
MOTION
It was moved, seconded and voted to approve the
new Procedure Guideline for Guideline
Development v 4.0.
It was moved and voted to approve the new
Procedure Guideline for General Imaging v 4.0 as
amended. (APPENDIX 44)
It was moved, seconded and voted to approve and
accept the five collaborative guidelines developed
with ACR; 1.ACR-SNM-SPR Practice Guideline for
the Performance of Adult and Pediatric
Radionuclide Cystograpy; 2. ACR-ASTRO-SNM
Practice Guideline for the Performance of Therapy
of Unsealed Radiopharmaceutical Sources; 3. ACRSNM-SPR Practice Guideline for the Performance of
104
Liver/Spleen Scintigraphy; 4. ACR-SNM-SPR
Practice Guideline for the Performance of Tumor
Scintigraphy (with Gamma Cameras); 5. ACR-SNMSPR Practice Guideline for the Performance of
Gastrointestinal Scintigraphy, as amended.
2010/0417BOD
MOTION
It was moved, seconded and voted to approve
adding the qualification of personnel in the guideline
on general imaging guideline” All nuclear medicine
examinations should be performed under the
supervision of and interpreted by a physicians
certified in Nuclear Medicine or Nuclear Radiology
by the American Board of Nuclear Medicine, the
American Board of Radiology, the Royal College des
medicines due Quebec, or the equivalent .In
addition, the physician should participate in
maintenance of certification in the field of nuclear
medicine.”
It was moved, seconded and voted to allow SNM
Leadership to develop a plan regarding
qualifications for interpreting nuclear medicine
studies, to take to the third party payers.
2010/0604BOD
2010/09113BOD
2010/0912BOD
2010/1210BOD
MOTION
MOTION
MOTION
MOTION
It was moved, seconded and voted to approve all
four guidelines; SNM Procedure Guideline on Breast
Scintigraphy with Breast-Specific Gamma Cameras,
SNM Procedure Guideline for Hepatobiliary
Scintigraphy, SNM Procedure Guideline for Sodium
18-F-Fluoride PET/CT Bone Scans, and SNM
Procedure Guideline for General Imaging V5.0.
(Appendix 26, 59, 60 and 61)
It was moved, seconded and voted to amend a
section of the general imaging guidelines – from
examples of clinical and research indications to
common clinical indications.
It was moved, seconded and voted that the SNM
Board of Directors approve and endorse the North
American Consensus Guideline for Administered
Radiopharmaceutical Activities in Children.
It was moved, seconded and voted to approve the
105
proposal (and budget) to evaluate half dose
protocol for Nuclear Cardiology Scan.
It was moved, seconded and voted to approve and
endorse the ATA Hyperthyroidism Management
Guideline (APPENDIX 45).
2011/0114BOD
MOTION
It was moved, seconded and unanimously voted to
approve the revised Credentialing Statement
(APPENDIX 46).
2011/0211BOD
MOTION
It was moved, seconded and voted unanimously to
table the approval the ACR-SNM Technical Standard
for Procedures Using Radiopharmaceutical Guideline
as amended (APPENDIX 47).
2011/0311BOD
MOTION
It was moved, seconded and voted to approve the
Cardiovascular Council position paper on radiation
exposure (APPENDIX 48).
2011/0603BOD
MOTION
It was moved, seconded and voted to approve the
ACR SNM Technical Standard for Procedures Using
Radiopharmaceuticals. (APPENDIX 50).
2011/0719BOD
MOTION
It was moved, seconded and unanimously voted to
approve the Practice Guideline for Lung Scintigraphy
V4.0 with the requested changes (APPENDIX 51).
It was moved, seconded and unanimously voted to
approve the Practice Guideline for Somatostatin
Receptor Scintigraphy V2.0 (APPENDIX 52).
2012/0320BOD
MOTION
It was moved and unanimously voted to approve
the EANM Guideline for I-131 and I-123 MIBG
Scintigraphy. (APPENDIX 72)
2011/0320BOD
MOTION
It was moved and unanimously voted to approve
the EANM Guideline for Radioimmunotherpay
(Zevalin) with a comment added: "Pretherapeutic
imaging with 111In-ibritumomab tiuxetan is no
longer mandatory in the United States" (APPENDIX
73)
106
PROFESSIONAL POLICES
960112BOD-12
SNM DIRECTORS AND LIABILITY COVERAGE
MOTION:
To approve the following agenda topic for the 1996
SNM Annual Business Meeting: RESOLVED, that an
additional article be added to the Articles of
Incorporation of the Society of Nuclear Medicine
(SNM) as Article VIII:
ARTICLE VIII
Limitation of Liability
The directors and officers of the Society shall
have no personal liability for monetary
damages to the Society or its members for
their conduct as directors or officers, provided,
that the liability of directors and officers shall
not be limited for acts or omissions that involve
intentional misconduct by them or a knowing
violation of law, an unlawful distribution or a
benefit in money, property or services to which
they are not legally entitled.
980607
MOTION:
It was moved, seconded and voted that a task force
be formed to revise the Statement on Credentialing
and Delineation of Privileges and that it be a
continue to be co-joint statement that other
organizations would also endorse. (Resolution, June
7, 1998, House of Delegates) Next review date
2003.
SNMTS PRESIDENT’S REPORT
Ms. Clarke reported on the activities of the SNMTS since the last meeting. She
specifically mentioned the efforts of the SNMTS in identifying the minimum
requirements for entry level into the profession of the nuclear medicine technology and
advanced practice. She asked the BOD to approve the Scope of Practice document
contained in the packet. The BOD approved the following motion.
020209
MOTION:
It was moved, seconded and voted to approve the
Scope of Practice document. (Resolution, February 9,
2002, Board Of Directors) Next review date 2007.
107
020614
MOTION:
It was moved, seconded and voted that the BOD
approves the Procedure for SNM Review of External
Procedure and Practice Guidelines.(Resolution,
June 14, 2002, Board of Directors) Next review
date 2007.
030620
MOTION:
It was moved, seconded and voted to approve the
2003 version of Essentials and Guidelines for an
Accredited Educational Program for the Nuclear
Medicine Technologist as presented by the JRCNMT.
(Resolution, June 20, 2003, Board of Directors) Next
review date 2008.
030620
MOTION:
It was moved, seconded and voted that the
Performance and Responsibility Guidelines for the
Nuclear Medicine Technologist (Revision 2003) be
adopted to include the Errata as presented at the
meeting. (Resolution, June 20, 2003, Board of
Directors) Next review date 2008.
2012/0515BOD
MOTION
It was moved, seconded and voted unanimously to
approve the paper and send it to ABNM to request
that they sign-on. If ABNM does not approve or
wishes to make major changes, their name will be
removed from the document. (APPENDIX 74)
108
RADAR
070713BOD
MOTION:
It was moved, seconded and voted that the
issue (establishing a committee seeking
$10,000) be tabled and the proposal be referred
to the Restructuring Task Force to evaluate
how to make most effective use of this
proposal in terms of organizational structure.
109
RadioImmunotherapy (RIT)
050918BOD
MOTION:
It was moved, seconded and voted to
approve acceptance of an unrestricted
educational grant from Biogen IDEC to launch
a national program to:
Develop educational and organizational materials to foster the spread and increased
utilization of RIT. Develop a database of those centers that have experience in the
use of radiopharmaceuticals for RIT.
110
SNM/ EDUCATION AND RESEARCH FOUNDATION
030405
MOTION:
It was moved, seconded and voted to approve the
ERF/SNM Alliance document. (Resolution, April 4-5,
2003, Board of Directors) Next review date 2008.
2010/0912BOD
MOTION
It was moved, seconded and voted that the
relationship of SNM with ERF as currently organized
should be guided by the following principles:
1.Identification of fundraising needs is developed
and approved by SNM with input from ERF.
2.Corporate fundraising is done by SNM, with help
from ERF when requested.
3.Grants from ERF are unrestricted funds for
education and research, unless the donor specifically
designates the purposes
4.SNM supports a strategic integration merger of ERF
with SNM.
It was moved, seconded and voted to:
1. Task force will be formed, 3 from SNM and 3 from
ERF)(including 1 tech each), along with Bob, Teri
and Virginia. To discuss how we can better fundraise
together.
2.SNM with the input of ERF will identify a
demonstration project. Suggested Timeline: The
demonstration project should be identified by
December 1.
3.The SNM BOD will review the ERF alliance
agreement document including ERF management –
ERF will update alliance agreement to move toward a
definite long term structure.
2011/0501BOD
MOTION
It was moved, seconded and unanimously voted to
approve the Named Award Guidelines. (APPENDIX 53)
111
TASK FORCES
951021BOD-06
RADIOPHARMACEUTICALS
MOTION:
950611BOD-09
ISOTOPE AVAILABILITY COMMITTEE
MOTION:
950610BOD-08
To retain the SNM Task Force on
Radiopharmaceuticals and to engage in the process to
establish it as a Commission of the Society.
The Society of Nuclear Medicine (SNM) strongly
supports funding for the NBTF project. Society of
Nuclear Medicine (SNM) also urges augmentation of
funding to support the Medical Applications Program.
APPROVED.
ISOTOPE AVAILABILITY COMMITTEE
MOTION:
The SNM is vehemently opposed to DOE using funds
from the medical application research budget to fund
further conceptual design studies for the NBTF from
either FY 1995 or FY 1996 allocations. APPROVED.
MOTION:
The DOE should make every effort to identify funding
that does not come out of medical application
research funds, to execute the NBTF project.
APPROVED.
960114
MOTION:
To accept the report of the Intersociety/Industry
Committee, as presented and to endorse
the mission statement and the four
assumptions and report that underlie
the whole process. (Resolution, January
14, 1996, House of Delegates) next
review date 2001.
980201
MOTION:
To approve SNM’s response to the Health Care
Financing Administration (HCFA) final rule regarding
physician supervision guidelines with the following
amendment to the document proposed at the House
of Delegates Meeting in Las Vegas: Changing the
word from “may” to “can” on the submitted Physician
Supervision Task Force Guideline document.
Submitted by : Ronald T. Tikofsky, Ph.D. (Resolution,
112
February 1, 1998, House of Delegates) Next review
date 2003.
010211
010622
020614
MOTION:
It was moved, seconded and voted to modify Goal #4
of the SNM Strategic Plan in the following manner:
Item #2 be deleted
Item #6 be deleted
Item #3 is reworded to exclude the phrases
“regulatory agencies” and “enhanced
monitoring of federal activities.”
Dr. Links will forward items 2, 6 and portions of 3 that
have been deleted to the ACNP for follow-up and
report back to the SNM. (Resolution, February 11,
2001, House of Delegates) Next review date 2006.
MOTION: It was moved, and seconded to adopt the following
formula for allocating expenses and revenues in
support of the Technologist Section:
1. The management fee will be eliminated and
the Technologist Section budget will be based
on actual expenditures and revenues for both
the direct and allocated activities, with the
allocated activities based on current
percentages.
2. Additional expenditures approved by the SNM
Board of Directors that were not part of the
joint SNM/SNMTS approved budget process
will not be charged to the Technologist
Section, unless they willingly agree to the
charge and were part of the generation of
the expenditure, in that current budget year
– even if they were allocated activities.
3. The allocation formula will be adjusted as
needed based on an annual review by both
the SNM and SNMTS financial committees.
4. This will begin with the 2001-2002-budget
year.
MOTION:
It was moved, seconded and approved for Dr.Gelfand
to establish a task force to investigate methods
for cooperating with other affiliated organizations and
representative groups. (Resolution June 14, 2002,
Board of Directors) Next review date 2007.
113
030620
MOTION:
It was moved, seconded and voted to develop a task
force to develop a strategic plan for government
relation’s activities to help guide the selection of
firms. (Resolution, June 14, 2002, Board of Directors)
Next review date 2007.
MOTION:
It was moved, seconded and voted to direct the
President to appoint a task force to develop a new
organizational component, with particular emphasis
on setting up a PET organization based on the
guidelines from the working group. (Resolution,
September 14, 2002, Board of Directors) Next review
date 2007.
MOTION:
Approval of Advanced Practice Nuclear Medicine
Technologist There was a motion to approve the
development of an Advanced Practice Technologist in
Nuclear Medicine; seconded. A friendly amendment
was suggested – establish task force to investigate
further; seconded and discussion. There was a Call
to Question; seconded and approved with two (2)
opposed.
MOTION:
It was moved, seconded and voted to support the
establishment of a task force to explore the
establishment of a middle level provider in nuclear
medicine known as the Advanced Practice Nuclear
Medicine Technologist. (Resolution, June 20, 2003,
Board of Directors) Next review date 2008.
MOTION:
It was voted, seconded, and approved that the SNM
Board approve the establishment of a task force to
work with various committees to explore educational
needs internationally and develop a comprehensive
program. (Resolution, June 20, 2003, Board of
Directors) Next review date 2008.
FALL 2004 SNM BOARD OF DIRECTORS MEETING
NRP Task Force - Dr. Thakur asked the BOD to review the outline, timeline and position
included in the BOD agenda packets to begin work towards congressional support for a
National Isotope Program. The BOD approved the following motion:
MOTION:
It was moved, seconded and voted to approve the
Task Force’s outline of activities to begin work
114
towards congressional support for a National Isotope
Program as attached in (Appendix 15).
060211BOD
MOTION:
It was moved, seconded and voted to approve the
proposal of the Technologist Section Management Fee
Task Force as recommended in their report to the
National Council. (Appendix 16)
115
Young Professionals Committee
090206
MOTION
It was moved, seconded and voted that the SNM
Board of Directors approve the conversion of the
Young Professionals Committee to a Standing
Committee of the BOD of the SNM.
116
SNMMI-TS
050617BOD
MOTION:
It was moved, seconded and voted to approve the
endorsement of baccalaureate level degree as entry
level for nuclear medicine technologists by 2015.
MOTION:
It was moved, seconded and voted to approve the
motion as amended, to endorse the establishment of
a middle level provider in nuclear medicine known as
the nuclear medicine practitioner.
MOTION:
It was moved, seconded and voted to endorse that
individuals practicing nuclear medicine technology, as
defined under the scope of practice of a nuclear
medicine technologist, must hold credentials given by
a nationally recognized certification body in nuclear
medicine, or be recognized by state licensure in order
to practice nuclear medicine technology.
060211BOD
MOTION:
It was moved, seconded and voted that SNM approve
the proposed Core Curriculum to meet the preprofessional educational requirements of NMT
programs. Given the time necessary to complete the
Core Curriculum and the NMT professional curriculum,
this would result in the necessity of NMTs having a
minimum of a 4 year degree for entry into the field.
The resolution approving the Entry-Level
requirements was approved by the SNMTS Executive
Committee and the SNMBOD in June 2005.
(Appendix 17)
060602BOD
MOTION: Be it resolved that SNM Approve the Revised Core
Competencies for the Nuclear Medicine Practitioner.
The resolution approving the Nuclear Medicine
Practitioner was approved in June 2005; the
resolution approving the first draft of the Core
Competencies was approved in February 2006.
(APPENDIX 18)
070531BOD
MOTION: It was moved, seconded, and voted that the SNM
and SNMTS incoming Presidents’ will discuss
shortening the time spent at the annual meeting
117
and come up with a formal plan to fix the schedule
and report back to the SNM Board at the September
BOD meeting.
070601BOD
MOTION:
It was moved, seconded approve the SNMTS
Scope of Practice. (APPENDIX 19)
MOTION:
It was moved, seconded and voted to approve the
SNMTS Strategic Plan. (APPENDIX 20)
MOTION:
It was moved, seconded and voted to approve
that the Professional Curriculum to meet the
professional portion of the NMT curriculum with
the understanding that the final professional
curriculum will be distributed, with supporting
materials, for approval at the June 2008 Executive
Board meeting. (APPENDIX 21)
080117BOD
MOTION:
It was moved, seconded and voted unanimously
to approve the title of Nuclear Medicine Advanced
Associate as the professional title for the
technologist advanced practice position.
080614BOD
MOTION:
It was moved, seconded and voted that beginning
October 1, 2008, the SNMTS will begin full
participation in the investment return (loss) of the
SNM Capital Fund. The SNMTS capital fund assets
will be invested in accordance with the investment
policy of SNM. The SNMTS capital assets will not
be segregated into their own account, but held as
part of the overall SNM Capital Fund assets.
MOTION:
It was moved, seconded and voted to approve the
Nuclear Medicine Advanced Associate curriculum as
amended. (APPENDIX 54)
MOTION:
It was moved, seconded and voted to approve the
BS Entry Level Curriculum. (APPENDIX 55)
090126BOD
MOTION:
It was moved, seconded and voted that SNM
Support Senate Bill 79 – “An Act to Regulate
Radiologists Assistants, Radiology Practitioner
Assistants and Nuclear Medicine Advanced
118
Associates; and For Other Purposes as written.
090418BOD
MOTION
It was moved, seconded and voted to approve the
NMAA Roles and Responsibilities document
(APPENDIX 56)
090912BOD
MOTION
It was moved, seconded, and voted to endorse the
development of nuclear medicine practice models for
physician/technologist partnerships, which will
improve the quality of studies within nuclear
medicine and ultimately, patient care.
090913BOD
MOTION
It was moved, seconded and voted that the SNM
Board of Directors approve the final draft of the
Accreditation Standards for Nuclear Medicine
Technologist Education, revised in 2009.
2010/0130BOD
MOTION
It was moved, seconded and voted to approve the
NMAA Scope of Practice. (APPENDIX 57)
2011/0603BOD
MOTION
It was moved, seconded, and voted to approve the
revised NMT Scope of Practice. (APPENDIX 58)
2012/0608BOD
MOTION
It was moved, seconded and voted to approve the
Nuclear Medicine Technologist Performance
Standards. (APPENDIX 80)
2012/0608BOD
MOTION
It was moved, seconded and voted to approve
adding the PDEF to the SNM, Inc. membership
renewal notices.
119